149 results on '"Crohn’s Disease"'
Search Results
2. INFLAMMATORY BOWEL DISEASE, SOCIAL IMPACTS AND QUALITY OF LIFE: A LITERATURE REVIEW
- Author
-
Ialy Beatriz Lima Ferreira, Maria Clara Teles de Souza, and Raísa Kettlyn Simões de Lima
- Subjects
ulcerative colitis ,sickness impact profile ,crohn’s disease ,Public aspects of medicine ,RA1-1270 - Abstract
Inflammatory bowel disease (IBD) is a continuous total or partial inflammation of the digestive tract, with Crohn's disease and ulcerative colitis being the most common forms of presentation. The most frequent signs and symptoms consist of abdominal pain, fatigue, bloody stools, diarrhea, weight loss, and vomiting, and there may be extra-intestinal manifestations. In developed countries, an increased incidence of IBD has been observed, particularly in young people of working age, impacting their quality of life as well as physical, social and psychological aspects. This is because once diagnosed with IBD, individuals encounter coping challenges, difficulties in acceptance, and lifestyle changes. Therefore, we sought to analyze the social impacts and quality of life of patients diagnosed with Inflammatory Bowel Disease. A literature review was conducted in PubMed, SciELO, BVS and LILACS databases, 20 articles met the established criteria, of which 10 were selected to compose the study. Articles published between 2016 and 2021 and relevant to the topic were included, and those that did not meet the inclusion criteria or did not comprise primary data, and were duplicates were excluded. The analyzed studies showed that there was a reduction in quality of life in patients with IBD, presenting as main factors associated with this restriction the disease activity, socioeconomic factors, and the patient's age. It was denoted that this negative aspect causes limitations, mainly in the biopsychosocial performance of patients with this condition. Therefore, it is noteworthy that biopsychosocial impacts result from the manifestation of Inflammatory Bowel Disease, which demonstrates the need for a qualified and humanized multidisciplinary follow-up during the evolution of these patients.
- Published
- 2021
- Full Text
- View/download PDF
3. Gummatous cutaneous tuberculosis associated with the use of infliximab for Crohn's disease
- Author
-
Lucas Campos Garcia, Everton Carlos Siviero do Vale, Maria de Lourdes Ferrari, and Lauro Damasceno de Carvalho Faria
- Subjects
Crohn's disease ,Tumor Necrosis Factor Receptor-Associated Peptides and Proteins ,Molecular target therapy ,Skin tuberculosis ,Dermatology ,RL1-803 - Abstract
Abstract As the treatment of infectious and parasitic diseases improved, the prevalence of these conditions declined. However, with the expansion of the use of immunobiologicals, opportunistic infections have emerged, especially under atypical presentations. The present study reports the case of a patient treated with infliximab for Crohn's disease, who presented diarrhea, weight loss, abdominal pain, fever, and subcutaneous erythematous nodules that evolved with spontaneous fluctuation and ulceration. With the finding of alcohol-resistant bacilli and Mycobacterium tuberculosis DNA in a cutaneous fragment, through polymerase chain reaction, the diagnosis of gummatous tuberculosis was confirmed, probably secondary to hematogenous dissemination from an intestinal focus.
- Published
- 2021
- Full Text
- View/download PDF
4. ASPECTOS SOCIODEMOGRÁFICOS E CLÍNICOS RELACIONADOS À DOENÇA DE CROHN EM ADOLESCENTES.
- Author
-
Santo Machado, Karine do Espírito, da Silva Thiengo de Andrade, Priscila Cristina, Teti Toledo, Thelma, Marcia Peres, Ellen, Ferraz Gomes, Helena, Silva de Almeida, Inez, Carvalho Leite, Dayana, and Silva Pêgas, Kelly dos Santos
- Subjects
- *
CROHN'S disease , *ACQUISITION of data methodology , *QUANTITATIVE research , *PUBLIC hospitals , *DESCRIPTIVE statistics , *MEDICAL records , *SOCIODEMOGRAPHIC factors , *SYMPTOMS , *ADULTS , *ADOLESCENCE - Abstract
Objective: To describe the sociodemographic and clinical characteristics of adolescents with Crohn's disease. Methods: A quantitative, case series study carried out in a public hospital in the State of Rio de Janeiro, Brazil. Data were collected from the medical records of six adolescents diagnosed with Crohn's disease, from March to August 2020. The data were analyzed using simple descriptive statistics. Results: Regarding the sociodemographic characteristics, there was a predominance of mixed race/ethnicity, age between 17 and 20 years, most have basic home sanitation, live with family members, on average 2.5 people per residence and regarding education (3;50%) showed school delay. Regarding clinical characteristics, (6; 100%) were in category A1, with concomitant involvement of the small and large intestines; disease restricted to the small intestine and involvement restricted to the large intestine. The characteristics of the disease are inflammatory, followed by penetrating and stenosing. Conclusion: The intrinsic and extrinsic changes caused by the disease, resulting from weight loss, inadequate nutrition or surgical processes, can lead adolescents to various disorders, not only in relation to health care, but also in other areas of life. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. CROHN'S DISEASE: GENERAL CHARACTERISTICS AND TREATMENT WITH ADALIMUMABE BIOPHARMACEUTICAL
- Author
-
S. A. Marques, E. E. Oliveira, L. Bizeto, J. L. R. Santos, and V. C. G. Soares
- Subjects
Crohn's disease ,risk factors ,Adalimumab ,TNF-alfa ,General Works - Abstract
Crohn's Disease (CD) is a chronic inflammatory disease that affects the gastrointestinal system. The etiology is not fully understood, however, genetic, immunological, microbiological and environmental factors are related to its genesis. The most common manifestations of this disease are diarrhea, abdominal pain, ulcers and fistulas. In the absence of adequate treatment it can evolve into extra intestinal complications and is also an important risk factor for colon and rectal cancer. The treatment of the disease is palliative and there is no cure for the disease, being considered only the period of remission of symptoms, as a good prognosis. The biopharmaceutical, Adalimumabe, produced by recombinant DNA technology has demonstrated efficacy in the treatment of this disease, as it prevents the action of TNF-α, a cytokine involved in inflammation and is abundant in individuals with CD. Although Adalimumabe has good results, its use leads to side effects that can be mild or fatal, such as the activation of tuberculosis.
- Published
- 2018
6. O PAPEL DA MICROBIOTA NA ETIOLOGIA DAS DOENÇAS INFLAMATÓRIAS INTESTINAIS.
- Author
-
Soares Cavalcante, Regina Márcia, Moura Lima, Murilo, Luz Parente, José Miguel, and do Nascimento Nogueira, Nadir
- Subjects
- *
CROHN'S disease , *INFLAMMATORY bowel diseases , *HUMAN microbiota , *INFLAMMATION , *ULCERATIVE colitis , *ETIOLOGY of diseases - Abstract
Inflammatory bowel disease is a chronic inflammatory process, with etiology not yet well established, of multifactorial nature, represented mainly by two phenotypes, ulcerative colitis (UC) and Crohn's disease (CD). About pathogenesis, it is believed that direct and indirect homeostasis between microbiota, intestinal epithelium and immune cells is disrupted by genetic and environmental factors such as antibiotic use, smoking, diets and stress, resulting in a poor state. chronic unregulated inflammation. Recent scientific evidence has shown that the human gut microbiota can produce antigenic factors that trigger persistent inflammation of the intestinal mucosa as observed in CD and UC. In the last two decades, with the advent of new "omic" technologies, there has been an expansion of possibilities to analyze in large proportion the genetic and metabolic profile of the intestinal microbial population, which is numerically the most representative in the human body. Thus, there was an exponential expansion of the understanding of the composition as well as the functions performed by the gut microbiome, which enabled the discovery of new horizons regarding mechanisms of action triggering the inflammatory processes of many chronic diseases with inflammatory bowel diseases, allowing the formulation and implementation of new therapeutic interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2020
7. Avaliação da atividade inflamatória da doença de Crohn por métodos seccionais de imagem.
- Author
-
Fialho Cantarelli, Bruno Cunha, de Oliveira, Rafael Santiago, Araújo Alves, Aldo Maurici, Jucá Ribeiro, Bruno, Velloni, Fernanda, and D'Ippolito, Giuseppe
- Subjects
- *
CROHN'S disease , *CROSS-sectional imaging , *MAGNETIC resonance , *MAGNETIC resonance imaging , *TOMOGRAPHY , *INFLAMMATORY bowel diseases , *ENDOSCOPIC ultrasonography - Abstract
The evaluation of inflammatory bowel activity in patients with Crohn’s disease has traditionally been a challenge, mainly because of the difficulty in gaining endoscopic access to the small bowel. Historically, barium-based contrast studies were the only option for the evaluation of inflammatory activity in Crohn’s disease. They were gradually replaced by cross-sectional imaging techniques, computed tomography enterography (CTE) and magnetic resonance enterography (MRE) now being the modalities of choice for such evaluations. Those two imaging methods have provided important information regarding intestinal wall involvement and extra- intestinal manifestations of Crohn’s disease, not only assessing lesion characteristics and complications but also quantifying inflammatory bowel activity. The objective of this article is to review the main technical aspects of CTE and MRE, together with their indications, contraindications, and limitations, as well as the CTE and MRE imaging characteristics of inflammatory activity in Crohn’s disease. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
8. Pellagra affecting a patient with Crohn's disease
- Author
-
Shi Hui, Lu Heng, Wang Shaodong, Wang Fangyu, and Wang Zhenkai
- Subjects
Crohn's disease ,Niacin ,Niacinamide ,Pellagra ,Dermatology ,RL1-803 - Abstract
Abstract: Pellagra is a nutritional disease caused by a deficiency of niacin. It may lead to death if not identified and treated timely. We review the literature and report a female patient presented with clinical features of pellagra as a complication of Crohn's disease.
- Published
- 2017
- Full Text
- View/download PDF
9. ANÁLISE DA RESPOSTA TECIDUAL E ATIVIDADE ANTINEUROINFLAMATÓRIA COLÔNICA DO METIL JASMONATO NA RETOCOLITE ULCERATIVA CRÔNICA INDUZIDA POR ÁCIDO TRINITROBENZENOSULFÔNICO EM RATOS.
- Author
-
Caliani Carrera, Alefe Luiz, Ferraro Moreno, Isabela, Fernando Besson, Jean Carlos, and Marçal Natali, Maria Raquel
- Subjects
- *
ENTERIC nervous system , *INTESTINAL diseases , *CROHN'S disease , *ESSENTIAL oils , *COLON (Anatomy) - Abstract
Intestine inflammatory diseases (IIDs) are characterized by a chronic inflammatory processes mainly, Crohn Disease (CD) and Ulcerative Rectocolites (URC). Natural products suggest therapeutic alternatives such as methyl jasmonate (MeJA) as a probable alternative treatment, with proven anti-inflammatory, antiproliferative and antioxidant activities. The compound is isolated from the essential oil of Jasminum grandiflorum. Potential tissue and neuro-inflammatory effect of MeJA at 300 mg/kg in adult rats with colitis was induced by trinitrobenzenosulfonic acid (TNBS). Rats were divided into four groups and euthanized after treatment. Samples of distal colon of 20 animals were employed to obtain transversal histological cuts. Morphometric analyses of intestine tunics were undertaken by samples of images by optic microscope; antineuroinflammatory profile of the enteric nervous system was also undertaken by microscopic evaluation of 30 ganglia in the myoenteric ganglia per animal in counting and characterization of inflammatory cells. Efficient simulation of IID by TNBS was reported by reduction of inflammatory cells in enteric ganglia, especially lymphocytes and monocytes; tissue regenerative effect in the submucus and muscular tunics. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. Azoor: Retinopatia externa oculta zonal aguda associada com doença autoimune.
- Author
-
Leal Lima, Carolina Correa, Gois da Fonsêca, Maria Luisa, and Galvarro Vianna, Raul Nunes
- Subjects
- *
CROHN'S disease , *SYMPTOMS , *DIAGNOSIS , *EYE pain , *AUTOIMMUNE diseases - Abstract
Acute zonal occult external retinopathy (AZOOR) was first described by Gass in 1993 as a syndrome with rapid loss of one or more large areas of the external retinal segments. Male, 35 years, with Crohn's disease complaining of occasional eye pain and right eye nictalopia since childhood. In regular use of azathioprine and mesalazine. better visual acuity 20/20 OU. At fundoscopy, hyperpigmented lesions in the right temporal arcade of the right eye, in trellis, accompanying local vasculature. After exclusion of differential diagnoses, Azoor's diagnosis was reached. Azoor is an idiopathic syndrome characterized by an acute onset of photopsy, scotoma or both and is typically associated with a persistent loss of visual function involving one or more areas of the external retina. Despite classic photopsy symptoms, the patient in question had an atypical clinical presentation. We describe a case of a peripheral male with choroidal thinning and associated autoimmune disease. Thus, we believe that further investigation is necessary to verify the etiology of choroidal alteration and its association with the specific disease. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
11. Manifestaciones Maxilofaciales de la Enfermedad de Crohn: consideraciones clínicas y dentales
- Author
-
Afonso, Áquila de Oliveira, Dallepiane, Felipe Gomes, Carneiro, Grace Kelly Martins, Gonçalves , Heuber de Sales, Braga , Marcos Dyllan de Souza, Oliveira , Raira Santos de, Pereira, Alexandra de Lima, Sena , César Vinícius Gato, Lima, Marcos Paulo Maia de, and Nogueira, Brenda Graziella Coêlho
- Subjects
Inflammatory bowel disease ,Crohn's disease ,Mouth ,Oral Lesions ,Enfermedad inflamatoria intestinal ,Doença de Crohn ,Boca ,Lesiones orales ,Enfermedad de Crohn ,Lesões orais ,Doença inflamatória intestinal - Abstract
Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) of the gastrointestinal tract of unknown cause. However, it is known that environmental factors, epigenetics, intestinal microbiota and genetic factors are known to play a significant role in the etiology of the disease. Thus, this study aimed to review the literature on oral manifestations resulting from Crohn's Disease, as well as the proper management of oral lesions. As methodological procedures, a literature review is adopted using the SciVerse Scopus, Scientific Electronic Library Online (Scielo), U.S. National Library of Medicine (PUBMED) and ScienceDirect, with the help of the Mendeley reference manager. The results indicate that oral lesions resulting from Crohn's Disease include lip edema, granulomatous nodular edema, deep linear ulcerations, mucogingivitis, aphthous ulceration, angular cheilitis and pyosestomatitis vegetans. The dentist must give the patient the necessary help by providing information on hygiene techniques and suggesting an increase in the number of consultations to control the manifestations. You must consult with the gastroenterologist to adjust the control of pharmacological therapy, all with the aim of providing the best alternative for the patient and improving their quality of life. La enfermedad de Crohn (EC) es una enfermedad inflamatoria intestinal crónica (EII) del tracto gastrointestinal de causa desconocida. Sin embargo, se sabe que los factores ambientales, la epigenética, la microbiota intestinal y los factores genéticos juegan un papel importante en la etiología de la enfermedad. Por lo tanto, este estudio tuvo como objetivo revisar la literatura sobre las manifestaciones orales derivadas de la Enfermedad de Crohn, así como el manejo adecuado de las lesiones orales. Como procedimientos metodológicos se adopta una revisión bibliográfica utilizando SciVerse Scopus, Scientific Electronic Library Online (Scielo), EE.UU. Biblioteca Nacional de Medicina (PUBMED) y ScienceDirect, con la ayuda del gestor de referencias de Mendeley. Los resultados indican que las lesiones orales resultantes de la enfermedad de Crohn incluyen edema labial, edema nodular granulomatoso, ulceraciones lineales profundas, mucogingivitis, ulceración aftosa, queilitis angular y piosestomatitis vegetante. El odontólogo debe brindar al paciente la ayuda necesaria brindándole información sobre técnicas de higiene y sugiriendo un aumento en el número de consultas para controlar las manifestaciones. Se debe consultar con el gastroenterólogo para ajustar el control de la terapia farmacológica, todo ello con el objetivo de brindar la mejor alternativa para el paciente y mejorar su calidad de vida. A doença de Crohn (DC) é uma doença inflamatória intestinal crônica (DII) do trato gastrointestinal de causa desconhecida. Entretanto, sabe-se que fatores ambientais, epigenética , microbiota intestinal e fatores genéticos são conhecidos pode exercer um papel significativo na etiologia da doença. Assim, esse estudo objetivou revisar a literatura acerca das manifestações orais decorrentes da Doença de Crohn, bem como o manejo adequado para as lesões orais. Como procedimentos metodológicos, adota-se revisão bibliográfica utilizando as bases de dados SciVerse Scopus, Scientific Eletronic Library Online (Scielo), U.S. National Library of Medicine (PUBMED) e ScienceDirect, com auxílio do gerenciador de referências Mendeley. Os resultados indicam que as lesões orais decorrentes da Doença de Crohn incluem o edema labial, edema nodular granulomatoso, ulcerações lineares profundas, mucogengivite, ulceração aftosa, queilite angular e piosestomatite vegetante. O médico dentista deve dar ao paciente a ajuda necessária proporcionando informação sobre as técnicas de higiene e sugerindo o aumento do número de consultas para o controlo das manifestações. Deve realizar interconsultas com o médico gastroenterologista para ajustar o controlo da terapia farmacológica, tudo isto com o fim de proporcionar a melhor alternativa para o paciente e melhorar a sua qualidade de vida.
- Published
- 2022
12. Sweet's syndrome associated with Crohn's disease
- Author
-
Caren dos Santos Lima, Roberta Duarte Bezerra Pinto, Heliana Freitas de Oliveira Góes, Simone de Abreu Neves Salles, Enoi Aparecida Guedes Vilar, and Carla dos Santos Lima
- Subjects
Crohn's disease ,Neutrophil infiltration ,Sweet's syndrome ,Dermatology ,RL1-803 - Abstract
Abstract: Sweet's syndrome is an uncommon benign skin disorder, whose pathogenesis remains unknown. Its classic form is more common in women and presents itself as papular-nodular, painful and erythematous or violaceous lesions. It mainly affects the face, neck, and upper limbs. Fever and neutrophilic leukocytosis are also common features. Although it is considered a systemic disease marker in more than half of patients, the association of this condition with Crohn's disease is rare, with few cases reported in the literature, of which, none in Brazil. We report the case of a patient with Crohn's disease who developed the classical features of Sweet's syndrome.
- Published
- 2017
- Full Text
- View/download PDF
13. Perfil de imunização em pacientes com Doença Inflamatória Intestinal / Immunization profile in patients with inflammatory bowel disease
- Author
-
Vitória Ortelan Filetti, Ana Clara Savignon Aride, Maria Eduarda Bonadiman Gonçalves, and Ana Paula Hamer Sousa Clara
- Subjects
Inflammatory Bowel Disease ,Crohn's disease ,Ulcerative Colitis ,Immunization. [Keywords] ,General Medicine ,Doença Inflamatória Intestinal ,Doença de Crohn ,Retocolite Ulcerativa ,Imunização. [Palavras-chave] - Abstract
Introdução: Doença de Crohn e retocolite ulcerativa são as formas mais comuns de doenças inflamatórias intestinais (DII), que se caracterizam por condições inflamatórias crônicas devidas à ativação imune inadequada. Pela heterogeneidade clínica das DII, torna-se imperativo ressaltar as peculiaridades quanto à vacinação nesses pacientes em razão da imunossupressão decorrente dos esquemas terapêuticos instituídos, verificando-sequais vacinas são preconizadas ou contraindicadas. Objetivo: Avaliar a imunização dos pacientes com DII e conscientizá-los, assim como os médicos, sobre a importância do cumprimento do calendário vacinal. Material e Método: Estudo transversal descritivo elaborado com base em coleta de dados feita por meio de questionários aplicados durante as consultas ou telefonemas acerca do status vacinal dos pacientes portadores de DII atendidos nos ambulatórios de DII, em Hospital filantrópico de Vitória/ES. A comprovação da vacinação foi feita diretamente pelo cartão, por fotos dos cartões via telefone, ou pelo prontuário do paciente. Resultados: O nível de imunossupressão depende da intensidade, duração e tipo de tratamento, influenciando diretamente na resposta vacinal e no risco e benefício de cada vacina, principalmente as de vírus vivos ou organismos vivos atenuados. Por outro lado, vacinas com organismos inativados sempre devem ser administradas. No estudo, entre os imunizantesanalisados, identificou-se que aquele contra o papilomavírus humano apresentou maior porcentagem de ausência (92%), e aquele contra hepatite B obteve maior porcentagem de esquemas completos (84,1%). Conclusão: As principais causas observadas de esquemas incompletos foram: ausência de direcionamento médico; ausência dos imunizantes nos centros de saúde; e negligência pessoal, apesar das informações fornecidas sobre a necessidade de vacinação. Assim, evidenciou-se a importância da relação médico-paciente, a necessidade de os profissionais de saúde atuarem na manutenção do cartão vacinal completo, bem como a de os pacientes se comprometerem a completar as vacinas. As informações obtidas servirão como base para futuras pesquisas, favorecendo as evidências de imunização em pacientes com DII. Palavras-chave: Doença de Crohn, Colite ulcerativa, Imunização, Cobertura Vacinal ABSTRACT: Introduction: Crohn’s Ddisease and Uulcerative Ccolitis are the most common forms of Iinflammatory Bbowel Ddisease (IBD’s), which are characterized by chronic inflammatory conditions due to inadequate immune activation. Due to the clinical heterogeneity of IBDs, it is imperative to emphasize the peculiarities regarding vaccination in these patients due to immunosuppression resulting from the therapeutic regimens instituted, verifying which vaccines are recommended or contraindicated. Objective: The aim of this study was to evaluate the immunization of patients with IBD’s and make them, as well as doctors, aware of the importance of complying with the vaccination schedule. Materials and Methods: This is a descriptive cross-sectional study prepared from the data collection collected through the questionnaires applied during consultations or through phone calls, about the immunization status of patients with IBD, who were treated at the IBD outpatient clinics, in the Hhospital philanthropic of Vitória, - ES. Proof of vaccination was made directly by the card, by photos of the cards via telephone, or by the patient’s medical record. Results: The level of immunosuppression depends on the intensity, duration, and type of treatment, directly influencing the vaccine response and the risk and benefit of each vaccine, especially those involving live viruses or live attenuated organisms. On the other handcontrary, vaccines with inactivated organisms should always be administered. In the this study, among the immunizations analyzed, it was identified that the one against Hhuman Ppapilloma Vvirus had the highest percentage of absence (92%), and the one against hepatitis B had the highest percentage of complete regimens (84.1%). Conclusion: The main observed causes of incomplete schedules wereincluded: lack of medical guidance; absence of immunizations in health centers; and personal negligence, despite being informed about the need for vaccination. Thus, the importance of the doctor-patient relationship was highlighted, as well as the need for health professionals to act in the maintenance of the complete vaccination card, in addition to the patients’ committing commitment to complete the vaccination schedulevaccines. The information obtained will serve as a basis for future research, favoring evidence of immunization in patients with IBD. Keywords: Crohn Disease, Colitis, ulcerative, Imunization, Vaccination coverage Abstract: Crohn's Disease and Ulcerative Colitis are the most common forms of Inflammatory Bowel Disease (IBD's), which are characterized by chronic inflammatory conditions due to inadequate immune activation. Due to the clinical heterogeneity of IBDs, it is imperative to emphasize the peculiarities regarding vaccination in these patients due to immunosuppression resulting from the therapeutic regimens instituted, verifying which vaccines are recommended or contraindicated. Objective: To evaluate the immunization of patients with IBD's and make them, as well as doctors, aware of the importance of complying with the vaccination schedule. Material/Method: Descriptive cross-sectional study prepared from data collection through questionnaires applied during consultations or through phone calls, about the immunization status of patients with IBD, treated at the IBD outpatient clinics, in Hospital philanthropic of Vitória - ES . Proof of vaccination was made directly by the card, by photos of the cards via telephone, or by the patient's medical record. Results: The level of immunosuppression depends on the intensity, duration and type of treatment, directly influencing the vaccine response and the risk and benefit of each vaccine, especially those involving live viruses or live attenuated organisms. On the other hand, vaccines with inactivated organisms should always be administered. In the study, among the immunizers analyzed, it was identified that the one against Human Papilloma Virus had the highest percentage of absence (92%), and the one against Hepatitis B had the highest percentage of complete regimens (84.1%). Conclusion: The main observed causes of incomplete schedules were: lack of medical guidance; absence of immunizations in health centers; and personal negligence, despite being informed about the need for vaccination. Thus, the importance of the doctor-patient relationship was highlighted, as well as the need for health professionals to act in the maintenance of the complete vaccination card, in addition to the patients committing to complete the vaccines. The information obtained will serve as a basis for future research, favoring evidence of immunization in patients with IBD.
- Published
- 2022
14. Manifestaciones orales y maxilofaciales de la enfermedad de Crohn: una revisión integradora
- Author
-
Afonso, Áquila de Oliveira, Leitão , Karoline Bittencourt Mendes, Araújo , Felipe Rafael da Cunha, Pereira , Alexandra de Lima, Girard, Bruna Peixoto, Nascimento, Wildecely Silva do, Santos, Priscila Moraes dos, Santos, Edmar Augusto, Oliveira Neto , José Lopes de, and Cintra , Thamires do Prado
- Subjects
Inflammatory bowel disease ,Mouth ,Enfermedad inflamatoria intestinal ,Doença de Crohn ,Boca ,Oral injuries ,Lesiones bucales ,Crohn's Disease ,Enfermedad de Crohn ,Lesões orais ,Doença inflamatória intestinal - Abstract
This study aimed to review the literature on oral manifestations resulting from Crohn's disease, deepening the knowledge of the dentist to provide, thus, better care to patients with CD. As methodological procedures, a bibliographic review was adopted using the SciVerse Scopus, Scientific Electronic Library Online (Scielo), U.S. National Library of Medicine (PUBMED) and ScienceDirect databases, with the assistance of the Mendeley reference manager. The results indicate that oral lesions resulting from Crohn's Disease include lip edema, granulomatous nodular edema, deep linear ulcerations, mucogingivitis, aphthous ulceration, angular cheilitis and pyosstomatitis vegetans. Oral manifestations of Crohn's Disease can impair the quality of life of patients who complain of discomfort from these lesions. Therefore, it is essential that health professionals are familiar with these disorders, since oral lesions can serve as fundamental indicators in the early diagnosis of the disease. Este estudio tuvo como objetivo revisar la literatura sobre las manifestaciones orales derivadas de la enfermedad de Crohn, profundizando en el conocimiento del odontólogo para brindar, así, una mejor atención a los pacientes con EC. Los procedimientos metodológicos, la revisión bibliográfica se adoptó utilizando el SciVerse Scopus, Scientific Electronic Library Online (Scielo), EE.UU. Bases de datos de la Biblioteca Nacional de Medicina (PUBMED) y ScienceDirect, con la asistencia del administrador de referencias de Mendeley. Los resultados indican que las lesiones orales resultantes de la enfermedad de Crohn incluyen edema labial, edema nodular granulomatoso, ulceraciones lineales profundas, mucogingivitis, ulceración aftosa, queilitis angular y piostomatitis vegetante. Las manifestaciones orales de la enfermedad de Crohn pueden afectar la calidad de vida de los pacientes que se quejan de molestias por estas lesiones. Por lo tanto, es fundamental que los profesionales de la salud estén familiarizados con estos trastornos, ya que las lesiones orales pueden servir como indicadores fundamentales en el diagnóstico precoz de la enfermedad. Esse estudo objetivou revisar a literatura acerca das manifestações orais decorrentes da doença de Crohn (DC), aprofundando os conhecimentos do cirurgião dentista para proporcionar, assim, um melhor atendimento ao paciente portador da DC. Como procedimentos metodológicos, adota-se revisão bibliográfica utilizando as bases de dados SciVerse Scopus, Scientific Eletronic Library Online (Scielo), U.S. National Library of Medicine (PUBMED) e ScienceDirect, com auxílio do gerenciador de referências Mendeley. Os resultados indicam que as lesões orais decorrentes da Doença de Crohn incluem o edema labial, edema nodular granulomatoso, ulcerações lineares profundas, mucogengivite, ulceração aftosa, queilite angular e piosestomatite vegetante. As manifestações orais da Doença de Crohn podem prejudicar a qualidade de vida do paciente que apresentam queixas de desconforto proveniente dessas lesões. Portanto, torna-se imprescindível que os profissionais da saúde estejam familiarizados com essas desordens, uma vez que as lesões orais podem servir como indicadoras fundamentais no diagnóstico precoce da doença.
- Published
- 2022
15. Metastatic Crohn’s disease despite infliximab therapy
- Author
-
Sara Campos, Inês Coutinho, José Carlos Cardoso, and Francisco Portela
- Subjects
Biological agents ,Crohn’s disease ,Granuloma ,Dermatology ,RL1-803 - Abstract
Abstract Metastatic Crohn’s disease is a rare extraintestinal manifestation of Crohn’s disease. It is characterized by polymorphic skin lesions formed by non-caseating granulomas located on anatomical sites distant from the gastrointestinal tract. We report a rare case of metastatic Crohn’s disease, simultaneously displaying multiple clinically heterogeneous cutaneous lesions, in a patient with previously diagnosed Crohn’s disease in remission due to anti-TNF-α use. This case highlights the need for high clinical suspicion and early biopsy in the setting of a patient with Crohn’s disease and persistent skin lesions, even under biologic therapy. Furthermore, it reinforces the need of monitoring of the serum level of infliximab, increasing the dose in case it is low or undetectable.
- Published
- 2017
- Full Text
- View/download PDF
16. THE IMPORTANCE OF COLONOSCOPY IN INFLAMMATORY BOWEL DISEASES
- Author
-
Márcio Alexandre Terra PASSOS, Fernanda Correa CHAVES, and Nilson CHAVES-JUNIOR
- Subjects
Inflammatory bowel disease ,Endoscopy ,Colonoscopy ,Crohn’s disease ,Ulcerative colitis ,Surgery ,RD1-811 ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
ABSTRACT Introduction: Endoscopic evaluation, particularly the macroscopic mucosal and histological results of ileocolic biopsies, is essential for the management of inflammatory bowel disease. Endoscopic appearance is not always sufficient to differentiate Crohn’s disease and ulcerative colitis, but there are some characteristics that favor one or another diagnosis. Both diseases have an increased incidence of colorectal carcinoma; so, surveillance colonoscopy is important for detecting early neoplastic lesions. Objective: To update the importance of endoscopy in the evaluation, diagnosis and prognosis of inflammatory bowel disease. Method: Search was done in the scientific literature of the TRIP database, chosen from clinical questions (PICO) with the following descriptors: “inflammatory bowel disease”, “endoscopy/colonoscopy”, “Crohn’s disease”, “ulcerative colitis” and “diagnosis/treatment”. Results: Endoscopic investigation in patients with chronic colitis is quite accurate for the differential diagnosis between ulcerative colitis and Crohn’s disease. Endoscopy is indicated for ulcerative colitis during severe crisis due to its prognostic value. Another accepted indication for endoscopy in inflammatory bowel disease is its use in the screening for dysplastic lesion. Conclusion: Ileocolonoscopy allows an accurate diagnosis of Crohn’s disease or ulcerative colitis in up to 90% of cases. The healing of the mucosa assessed by endoscopy after treatments despite not being consensus is still the gold-standard in the evaluation of remission of the disease. Colonoscopy is essential for long-term cancer surveillance and in the future the implementation of Confocal Laser Endomicroscopy seems to be very promising in assessing the initial dysplasia.
- Published
- 2018
- Full Text
- View/download PDF
17. Aspectos clínicos y diagnósticos del Síndrome de Crohn
- Author
-
Aguiar , Ulisses Nogueira de, Aguiar , Maria Pereira de Queiroga, Sá, Luiz Fernando Pereira de, Mata, João Paulo de Oliveira, Teixeira , Atílio da Silva, Crisanto, Antonio Vinícius Sales de Moraes Souza, Amorim, Gabriela Rodrigues, Pinheiro, Flávia Piauilino, Guilhon, Luana Amorim, Silva, Ícaro Avelino, Sousa, Gabriel Franco de, Gonçalves, Walquer Vinicius Esteves, Martins , Luana Araújo, Rocha, Thaise Silva, and Silva , Amanda Miranda da
- Subjects
Crohn's disease ,Doença intestinal ,Doença de Crohn ,Immune system disease ,Enfermedad del sistema inmunológico ,Intestinal disease ,Enfermedad de Crohn ,Enfermedad intestinal ,Doença do sistema imune - Abstract
Crohn's disease (CD) is an inflammatory bowel disease that affects part of the population between 20 and 50 years of age, of both sexes. This disease affects people from different socioeconomic classes and nationalities, and affects approximately 1.4 million of people in the United States only. This work aims to talk a little about the disease and report possible complications, diagnosis and treatment of the disease. This review is intended to help bring more knowledge about the disease using the set of several articles to confirm the information. The work developed is an exploratory study, carried out through a systematic review research. According to Marconi and Lakatos (2011), a systematic search covers the entire bibliography already made public in relation to the subject of study. The search strategy used to obtain the articles was the important databases in the health area, with MEDLINE (Medical Literature Analysis and Retrieval System), Science Direct and SCIELO (Scientific Electronic Library Online), ARCA (Fiocruz Institutional Repository), Lilics available online in full text, published in Portuguese (Brazil), English and Spanish. The following descriptors were applied: AUTOIMMUNE DISEASE, CROHN'S DISEASE, INTESTINE SYNDROME. A total of 10,050 articles were found in the scientific databases: Latin American and Caribbean Literature on Health Sciences (LILACS), MEDLINE (Medical Literature Analysis and Retrieval System), Science Direct and SCIELO (Scientific Electronic Library Online), ARCA (Repository Institutional of Fiocruz), Lilics. The following descriptors were used: AUTOIMMUNE DISEASE, CROHN'S DISEASE, INTESTINE SYNDROME, in English, Portuguese and Spanish. Where we obtained the articles described below in table 1 and discussed in the form of topics related to the topic. The present study shows that there are still many problems in identifying the disease, as most doctors research infectious diseases, but this disease, although mysterious, has treatment and diagnosis, which are already used in everyday life and need to be improved for a better quality of life for patients. La enfermedad de Crohn (EC) es una enfermedad inflamatoria intestinal que afecta a parte de la población entre 20 y 50 años, de ambos sexos. Esta enfermedad afecta a personas de diferentes clases socioeconómicas y nacionalidades, y afecta aproximadamente a 1,4 millones de personas solo en los Estados Unidos. Este trabajo tiene como objetivo hablar un poco sobre la enfermedad e informar de posibles complicaciones, diagnóstico y tratamiento de la enfermedad. Esta revisión tiene como objetivo ayudar a aportar más conocimientos sobre la enfermedad utilizando el conjunto de varios artículos para confirmar la información. El trabajo desarrollado es un estudio exploratorio, realizado a través de una investigación de revisión sistemática. Según Marconi y Lakatos (2011), una búsqueda sistemática cubre toda la bibliografía ya hecha pública en relación con el tema de estudio. La estrategia de búsqueda utilizada para la obtención de los artículos fueron las bases de datos importantes en el área de la salud, con MEDLINE (Medical Literature Analysis and Retrieval System), Science Direct y SCIELO (Scientific Electronic Library Online), ARCA (Fiocruz Institutional Repository), Lilics disponible online en texto completo, publicado en portugués (Brasil), inglés y español. Se aplicaron los siguientes descriptores: ENFERMEDAD AUTOINMUNE, ENFERMEDAD DE CROHN, SÍNDROME INTESTINO. Se encontraron un total de 10.050 artículos en las bases de datos científicas: Literatura Latinoamericana y del Caribe en Ciencias de la Salud (LILACS), MEDLINE (Sistema de Análisis y Recuperación de Literatura Médica), Science Direct y SCIELO (Biblioteca Electrónica Científica en Línea), ARCA (Repositorio Institucional de Fiocruz), Lilics. Se utilizaron los siguientes descriptores: ENFERMEDAD AUTOINMUNE, ENFERMEDAD DE CROHN, SÍNDROME INTESTINO, en inglés, portugués y español. Donde obtuvimos los artículos descritos a continuación en la tabla 1 y discutidos en forma de temas relacionados con el tema. El presente estudio muestra que aún existen muchos problemas en la identificación de la enfermedad, ya que la mayoría de los médicos investigan enfermedades infecciosas, pero esta enfermedad, aunque misteriosa, tiene tratamiento y diagnóstico, que ya se utilizan en la vida cotidiana y necesitan ser mejorados para una mejor calidad. de vida para los pacientes. A doença de Crohn (DC) é uma doença inflamatória intestinal, que acomete parte da população entre 20 a 50 anos de idade, de ambos os sexos. Essa doença acomete pessoas de diferentes classes socioeconômicas, e nacionalidade, e afeta aproximadamente 1,4 milhões de pessoas somente nos Estados Unidos. Esse trabalho tem como objetivo falar um pouco sobre a doença e relatar possíveis complicações, diagnóstico e tratamento da doença. Essa revisão pretende auxiliar levando mais conhecimento sobre a doença utilizando o conjunto de vários artigos para confirmação das informações. O trabalho desenvolvido é um estudo do tipo exploratório, realizado através de uma pesquisa de revisão sistemática. Segundo Marconi e Lakatos (2011), uma pesquisa sistemática abrange toda a bibliografia já tornada pública em relação ao tema de estudo. A estratégia de busca utilizada para obtenção dos artigos foram as bases de dados importantes na área de saúde, tendo a MEDLINE (Medical Literatura Analysis and Retrieval Sistem), Science Direct e SCIELO (Scientific Electronic Library Online), ARCA (Repositório Institucional da Fiocruz), Lilics disponíveis online em texto completo, publicados em língua portuguesa (do Brasil), inglesa e espanhola. Os seguintes descritores foram aplicados: DOENÇA AUTOIMUNE, DOENÇA DE CROHN, SINDROME INTESTINAL. Foram encontrados um total de 10.050 artigos nas bases cientificas: Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS), MEDLINE (Medical Literatura Analysis and Retrieval Sistem), Science Direct e SCIELO (Scientific Electronic Library Online), ARCA (Repositório Institucional da Fiocruz), Lilics. Foram utilizados como descritores: DOENÇA AUTOIMUNE, DOENÇA DE CROHN, SINDROME INTESTINAL, nos idiomas inglês, português e espanhol. Onde obtivemos os artigos abaixo descritos na tabela 1 e discutidos em forma de tópicos relacionados com o tema. O presente estudo mostra que ainda existem muitos problemas na identificação da doença, já que a maioria dos médicos pesquisam doenças infecciosas, porém essa doença ainda que misteriosa possui tratamento e diagnóstico, que já são utilizados no dia a dia e que necessitam ser aprimorados para uma maior qualidade de vida dos pacientes.
- Published
- 2022
18. PROBIÓTICOS NA TERAPIA NUTRICIONAL DA DOENÇA DE CROHN.
- Author
-
MOURA DOS SANTOS, GLEYSON, CAMPELO FARIAS, VANESSA GERMANA, SILVA BARBOSA, GLIANE, CARVALHO NEIVA, RENATA, PINTO ANDRADE, MARIA CLARA, and PEREIRA DOS SANTOS DUARTE, ENNYA CRISTINA
- Published
- 2018
19. Case for diagnosis. Metastatic Crohn's disease
- Author
-
João Renato Vianna Gontijo, Franciele Antonieta Bianchi Leidenz, and Maria Silvia Laborne Alves de Sousa
- Subjects
Crohn's disease ,Granuloma ,Granulomatous disease, chronic ,Skin manifestations ,Dermatology ,RL1-803 - Abstract
Abstract: Metastatic Crohn's disease is a rare skin manifestation, defined by granulomatous skin lesions that are discontinuous to the affected gastrointestinal tract and histopathologically resembling inflammatory bowel lesions. Up to 44% of patients with Crohn's disease have cutaneous manifestations, of which metastatic lesions are the least common. We present a case of an adolescent with refractory Crohn's disease and persistent papules and plaques on the skin.
- Published
- 2016
- Full Text
- View/download PDF
20. Video-assisted anal fistula treatment: technical considerations and preliminary results of the first brazilian experience
- Author
-
Carlos Ramon Silveira MENDES, Luciano Santana de Miranda FERREIRA, Ricardo Aguiar SAPUCAIA, Meyline Andrade LIMA, and Sergio Eduardo Alonso ARAUJO
- Subjects
Rectal fistula ,Surgical procedures ,Minimally invasive ,Fecal incontinence ,Crohn's disease ,Surgery ,RD1-811 ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Backgroung : Anorectal fistula represents an epithelized communication path of infectious origin between the rectum or anal canal and the perianal region. The association of endoscopic surgery with the minimally invasive approach led to the development of the video-assisted anal fistula treatment. Aim : To describe the technique and initial experience with the technique video-assisted for anal fistula treatment. Technique : A Karl Storz video equipment was used. Main steps included the visualization of the fistula tract using the fistuloscope, the correct localization of the internal fistula opening under direct vision, endoscopic treatment of the fistula and closure of the internal opening which can be accomplished through firing a stapler, cutaneous-mucosal flap, or direct closure using suture. Results : The mean distance between the anal verge and the external anal orifice was 5.5 cm. Mean operative time was 31.75 min. In all cases, the internal fistula opening could be identified after complete fistuloscopy. In all cases, internal fistula opening was closed using full-thickness suture. There were no intraoperative or postoperative complications. After a 5-month follow-up, recurrence was observed in one (12.5%) patient. Conclusion : Video-assisted anal fistula treatment is feasible, reproducible, and safe. It enables direct visualization of the fistula tract, internal opening and secondary paths.
- Published
- 2014
- Full Text
- View/download PDF
21. Incid?ncia e preval?ncia estimadas de doen?as inflamat?rias intestinais no estado do Rio Grande do Sul - Brasil
- Author
-
Cassol, Ornella Sari, Padoin, Alexandre Vontobel, and Hossne, Rog?rio Saad
- Subjects
Epidemiology ,MEDICINA [CIENCIAS DA SAUDE] ,Preval?ncia ,Incidence ,Doen?a de Crohn ,Prevalence ,Doen?as Inflamat?rias Intestinais ,Ulcerative Colitis ,Crohn's Disease ,Incid?ncia ,Epidemiologia ,Inflammatory Bowel Diseases ,Retocolite Ulcerativa - Abstract
A doen?a de Crohn (DC) e a retocolite ulcerativa (RCU) envolvem duas entidades denominadas de doen?as inflamat?rias intestinais (DIIs). Ambas t?m as mesmas caracter?sticas evolutivas e respostas terap?uticas semelhantes, mas devem ser consideradas duas doen?as diferentes. Tem altas taxas de incid?ncia e preval?ncia em pa?ses desenvolvidos; por?m, nos ?ltimos anos, observa-se mudan?a na cl?ssica distribui??o geogr?fica das DIIs, com taxas crescentes em regi?es tradicionalmente de pouca incid?ncia. Este estudo tem como objetivo estimar as taxas de incid?ncia e preval?ncia das DIIs no estado do Rio Grande do Sul, entre os anos de 2014 e 2019. Estudo transversal, observacional e anal?tico. Foram inclu?dos pacientes que iniciaram seu tratamento para DII e preencheram crit?rios para inclus?o no programa de fornecimento gratuito de medicamentos do Rio Grande do Sul. Os dados foram obtidos a partir dos cadastrados ou da renova??o dos mesmos junto ?s farm?cias estaduais de alto custo. As popula??es masculina, feminina e a total foram estimadas com base nos dados do Instituto Brasileiro de Geografia e Estat?stica, no meio de cada ano do estudo, e foram consideradas como refer?ncia para o c?lculo das taxas de incid?ncia e preval?ncia das DIIs para o per?odo em que o paciente foi designado. As an?lises inclu?ram m?dia, desvio padr?o e valores m?nimo e m?ximo. Achados com valor p ? 0,05 foram considerados estatisticamente significativos. Foram inclu?dos 1.082 pacientes com DIIs de ambos os sexos, sendo 57,5% do sexo feminino e 42,5% do sexo masculino. A DC correspondeu a 72,45%, e a RCU, a 27,54% dos pacientes. A preval?ncia no per?odo analisado foi de 9,51 a cada 100.000 habitantes, sendo 6,89 para DC e 2,62 para RCU. As incid?ncias para cada 100.000 habitantes anuais foram: 2,54 em 2014, 2,61 em 2015, 1,91 em 2016, 0,80 em 2017, 0,83 em 2018 e 0,96 em 2019. A taxa m?dia das incid?ncias a cada 100.000 habitantes foi de 1,61, sendo 1,17 para DC e 0,44 para RCU. A idade m?dia correspondeu a 41 anos, com predom?nio de 30-40 anos. A preval?ncia por regi?o foi maior na Regi?o Metropolitana, sendo de 12,69 a cada 100.000 habitantes. Este ? o primeiro estudo no estado do Rio Grande do Sul com dados de incid?ncia e preval?ncia das DIIs. Demonstrou preval?ncia similar a outros estudos e queda das taxas anuais de incid?ncia. Sugerimos mais estudos nessa ?rea, para compreendermos melhor qual est?gio epidemiol?gico o estado do Rio Grande do Sul est? vivendo. Crohn`s disease (CD) and Ulcerative Colitis (UC) involve two entities, called inflammatory bowel diseases (IBD). Both have the same evolutionary characteristics and similar therapeutic responses, but two different diseases must be considered. It has high incidence and prevalence rates in developed countries, but in recent years there has been a change in the classical geographic distribution of IBD, with increasing rates in regions traditionally with low incidence. This study aims to estimate the incidence and prevalence rates of inflammatory bowel diseases in the state of Rio Grande do Sul (RS), between the years 2014 to 2019. Crosssectional, observational, and analytical study. Patients who started their treatment for IBD and who met the criteria for inclusion in the free drug supply program in RS were included. Data obtained from those registered or from their renewal together with high-cost pharmacies in RS. The male, female, and total population, estimated based on Brazilian Institute of Geography and Statistics (IBGE) data in the middle of each year of the study, is considered as a reference to calculate the incidence and prevalence rates of IBD for the period in wich the patient was designated. Analyses included mean, standard deviation, and minimum and maximum values. Findings with p value ? 0,05 were considered statistically significant. 1082 patients with IBD of both genders were included, 57,5% female and 42,5% male. CD corresponded to 72,45% and UC to 27,54% of patients. The prevalence in the anlyzes period was 9,51 per 100.000 inhabitants, being 6,89 for CD and 2,62 por UC. The incidences per 100.000 inhabitants per year were: 2,54 in 2014, 2,61 in 2015, 1,91 in 2016, 0,80 in 2017, 0,83 in 2018 and 0,96 in 2019. The average rate of incidences per 100.000 inhabitants were 1,61, 1,17 for DC and 0,44 for UC. The average age corresponds to 41 years, with a predominance of 30-40 years. The prevalence by the region was higher in the metropolitan area, 12,69 per 100.000 inhabitants. This is the first study in the state of RS with data on the incidence and prevalence of IBD. It demonstrated similar prevalence to other studies and a drop in annual incidence rates. We suggest further studies in these areas to better understand which epidemiological stage the state of RS is experiencing. Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior - CAPES
- Published
- 2022
22. The role of chemokines and adipokines as biomarkers of Crohn's disease activity : a systematic review of literature
- Author
-
Mello, Juliana Delgado Campos, 1985, Leal, Raquel Franco, 1977, Montes, Ciro Garcia, Zaltman, Cyrla, Universidade Estadual de Campinas. Faculdade de Ciências Médicas, Programa de Pós-Graduação em Ciências da Cirurgia, and UNIVERSIDADE ESTADUAL DE CAMPINAS
- Subjects
Inflammation ,Inflamação ,Crohn's disease ,Quimiocinas ,Adipokines ,Doença de Crohn ,Doenças inflamatórias intestinais ,Inflammatory bowel diseases ,Chemokines ,Adipocinas - Abstract
Orientador: Raquel Franco Leal Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas Resumo: Introdução: A doença de Crohn (DC) é uma doença inflamatória intestinal (DII) que afeta o trato gastrointestinal e pode ter um grande impacto na qualidade de vida do paciente e nas atividades sociais/profissionais. Pacientes assintomáticos, ou com sintomas leves, experimentam a doença ativa com manifestação subclínica. A revisão sistemática (RS) foi realizada procurando evidências para o papel das quimiocinas e adipocinas como marcadores para a atividade da DC. Métodos: Esta RS foi conduzida por meio de pesquisas publicadas em bancos de dados internacionais e regionais até julho de 2020. Os pacientes com DC eram adultos, com a doença em atividade ou remissão. Todas as adipocinas e quimiocinas foram consideradas para a análise e o sistema Rayyan QCRI foi utilizado. Resultados: No total, foram incluídos 20 estudos. Seis abordaram quimiocinas, oito adipocinase seis abordaram ambos como potenciais biomarcadores da atividade de DC. CXCL8 foi a quimiocina mais estudada (8 estudos) e os resultados foram controversos, com 62,5% mostrando associação significativa com a atividade da DC. O CXCL10 foi investigado por 4 estudos e 50% o identificou como um potencial biomarcador. CCL2, CCL11, CCL26 e CXCL1 foram examinados por 2 artigos cada. CXCL8 (p=0,002 / p=0,001) e CXCL1 (p
- Published
- 2022
23. DOENÇA DE CROHN NO IDOSO: RELATO DE CASO.
- Author
-
SILVA SANCHES, BHEATRIZ RESOLEM and KAZUHIRO WATANABE, HÉLCIO
- Abstract
Crohn's disease is an inflammatory bowel disease, chronic relapsing disease, characterized by a granulomatous transmural inflammation that may affect any segment of the gastrointestinal tract. We believe that genetic and environmental factors influence in poor regulation of intestinal immunity, which leads to gastrointestinal tract injury. The clinical presentation is variable, with chronic diarrhea (the most common symptom); abdominal pain; weight loss; blood and/or mucus in feces; urgency and/or fecal incontinence; fistula; perianal fistula. Currently, the diagnosis is established by a combination of clinical presentation, endoscopic findings, radiological, histological, surgical, more recently, serologic studies. The diagnosis has bimodal distribution: its first peak occurs in patients between 15 and 30 years old, and 30% of the patients are diagnosed before their 20's; the second peak occurs between their 60's and 80's, with a lower incidence than the first peak. In the present study, we describe a case of a 67-year-old woman whose diagnosis was made on the second peak, and its first presentation started with appendicitis/colitis, requiring surgical treatment immediately. Thus, her diagnosis was based on its clinical presentation associated to the result of the histopathological evaluation. The patient in question has developed an enterocutaneous fistula, which was surgically approached due to failure of conservative treatment, but ended up coming to death due to her weakened clinical condition. A portion of patients who undergo surgical treatment is in adverse clinical conditions at the time of surgery, and has limited reserves to face the complications that might occur in the postoperative period, since the surgery is closely associated with risk of immediate infectious complications, and, subsequently, the risk of recurrence and short bowel syndrome. This case confirms the DC descriptions in the literature, demonstrating its incurable and recurrent characteristic. [ABSTRACT FROM AUTHOR]
- Published
- 2017
24. Linear IgA dermatosis associated with ulcerative colitis: complete and sustained remission after total colectomy
- Author
-
Thiago Jeunon de Sousa Vargas, Mônica Fialho, Luiza Tavares dos Santos, Palmira Assis de Jesus Barreto Rodrigues, Ana Luisa Bittencourt Sampaio Jeunon Vargas, and Maria Auxiliadora Jeunon Sousa
- Subjects
Colectomy ,Crohn's disease ,Dapsone ,Immunoglobulin A ,Proctocolitis ,Dermatology ,RL1-803 - Abstract
Linear IgA dermatosis has been increasingly associated with inflammatory bowel diseases, particularly ulcerative colitis. A 13-year-old male patient with an 11-month history of ulcerative colitis developed vesicles, pustules and erosions on the skin of the face, trunk and buttocks and in the oral mucosa. The work-up revealed a neutrophil-rich sub-epidermal bullous disease and linear deposition of IgA along the dermoepidermal junction, establishing the diagnosis of linear IgA dermatosis. The patient experienced unsatisfactory partial control of skin and intestinal symptoms despite the use of adalimumab, mesalazine, prednisone and dapsone for some months. After total colectomy, he presented complete remission of skin lesions, with no need of medications during two years of follow-up. A review of previously reported cases of the association is provided here and the role of ulcerative colitis in triggering linear IgA dermatosis is discussed.
- Published
- 2013
- Full Text
- View/download PDF
25. The importance of the multidisciplinary team in the view of the patient with Inflammatory Bowel Disease
- Author
-
Herrerias, Giedre Soares Prates [UNESP], Universidade Estadual Paulista (Unesp), and Sassaki, Lígia Yukie [UNESP]
- Subjects
Retocolite ulcerativa ,Crohn's disease ,Ulcerative colitis ,Doença de Crohn ,Inflammatory Bowel Disease ,Doenças Inflamatórias Intestinais ,Equipes de saúde - Abstract
Submitted by GIÉDRE SOARES PRATES HERRERIAS (giedre.prates@unesp.br) on 2022-02-23T00:14:13Z No. of bitstreams: 1 dissertacao_mestrado_giedre_herrerias.pdf: 17154197 bytes, checksum: 8d0695462977834ddbb2140749e9bdc9 (MD5) Approved for entry into archive by Elida Daniele de Antonio null (elida_daniele@btu.unesp.br) on 2022-02-23T10:57:42Z (GMT) No. of bitstreams: 1 herrerias_gsp_me_bot.pdf: 17154197 bytes, checksum: 8d0695462977834ddbb2140749e9bdc9 (MD5) Made available in DSpace on 2022-02-23T10:57:42Z (GMT). No. of bitstreams: 1 herrerias_gsp_me_bot.pdf: 17154197 bytes, checksum: 8d0695462977834ddbb2140749e9bdc9 (MD5) Previous issue date: 2021-12-17 Introdução: Doença inflamatória intestinal (DII) caracteriza-se por inflamação crônica do intestino, e suas formas mais comuns são a Doença de Crohn (DC) e a Retocolite Ulcerativa (RCU) que necessitam de cuidado contínuo. O contato constante com a equipe multiprofissional e a qualidade do atendimento interferem na adesão ao tratamento e na qualidade de vida (QV) dos pacientes, e consequentemente, na eficácia do tratamento. Consensos internacionais recomendam que os centros de referência em DII devem ser compostos por equipe multidisciplinar, com a presença de gastroenterologista clínico, coloproctologista ou cirurgião do aparelho digestivo, nutricionista, enfermeiro e psicólogo, entre outros profissionais. O objetivo do estudo foi avaliar a importância da equipe multidisciplinar na visão dos pacientes com DII. Métodos: Foi desenvolvido um estudo transversal e descritivo, com inclusão de 114 pacientes atendidos no Ambulatório de DII do Hospital das Clínicas da Faculdade de Medicina de Botucatu. Os dados sociodemográficos e clínicos, juntamente com a relevância da equipe multidisciplinar, foram avaliados. A importância da equipe multidisciplinar foi avaliada por meio de questionário específico desenvolvido para a pesquisa com as respostas: nada importante, sem importância, importante e muito importante para cada profissional. Os pacientes listaram os profissionais em ordem de importância. A QV foi avaliada pelo questionário IBDQ. A adesão ao tratamento e o conhecimento da doença foram avaliados pelos questionários Morisky e CCKNOW, respectivamente. Resultados: Foram incluídos 69 (60,53%) pacientes com DC e 45 (39,47%) com RCU. A idade média foi de 39,16±13,50 anos, 67 (58,77%) do sexo feminino. O tempo de diagnóstico foi de 9,88±7,35 anos. Presença de comorbidades foi observada em 52,63% da amostra. Cem por cento dos pacientes realizaram consultas com o gastroenterologista clínico, e menos da metade com psicólogo (48,25%), nutricionista (47,37%), enfermeiro DII (43,86%) e coloproctologista (42,98%). Observou-se que os atendimentos do enfermeiro e coloproctologista são mais prevalentes nos pacientes com DC. As três categorias citadas como muito importante/importante foram: gastroenterologista (99,12%), coloproctologista (96,55%) e endoscopista (93,47%), em 4ª posição o enfermeiro especialista em DII (93,26%), em 6ª posição o nutricionista (90,63%) e em 10ª posição o psicólogo (84,61%). A QV foi considerada excelente ou boa em 45,61% dos pacientes. A adesão ao medicamento foi baixa em 58,88% dos pacientes. O conhecimento sobre a doença foi baixo (6,21 ± 3,99 pontos), sendo maior dentre os pacientes com DC (p = 0,01). Conclusão: Os pacientes consideraram os médicos como os profissionais mais importantes no seu atendimento. Embora o serviço conte com equipe multidisciplinar, nem todos os pacientes tiveram oportunidade de passar em consulta com todos os profissionais. A falta de contato com toda a equipe, principalmente com o enfermeiro, pode ter contribuído para a baixa adesão medicamentosa e para o baixo conhecimento da doença, impactando no controle da doença e na QV. O cuidado holístico ao paciente é recomendado, enfatizando a importância de todos os profissionais do atendimento multidisciplinar para todos os pacientes com DII. Introduction: Inflammatory bowel disease (IBD) is characterized by chronic bowel inflammation, and its most common forms are Crohn's Disease (CD) and Ulcerative Colitis (UC) that require continuous care. The constant contact with the multidisciplinary team and the quality of care interferes in the adherence to the treatment and in the patient’s quality of life (QL), and, consequently, in the effectiveness of the treatment. International consensus recommends that IBD reference centers should be composed of a multidisciplinary team, with the presence of a gastroenterologist, coloproctologist, nutritionist, nurse and psychologist, among other professionals. The aim of the study was to assess the importance of the multidisciplinary team in the view of patients with IBD. Methods: A cross-sectional and descriptive study was carried out, including 114 patients from a tertiary center. Sociodemographic and clinical data, along with the relevance of the multidisciplinary team, were assessed. The importance of the multidisciplinary team was assessed through a questionnaire developed for the survey with the answers: nothing important, unimportant, important, and very important for each professional. Patients listed professionals in order of importance. QoL was assessed using the IBDQ questionnaire. Adherence to treatment and knowledge of the disease were assessed using the Morisky and CCKNOW questionnaires, respectively. Results: In total, 69 (60.53%) patients with CD and 45 (39.47%) with UC were included. The mean age was 39.16±13.50 years, 67 (58.77%) were female. The time from diagnosis was 9.88±7.35 years. Presence of comorbidities was observed in 52.63% of the sample. One hundred percent of patients had consultations with a clinical gastroenterologist, and less than half with a psychologist (48.25%), a nutritionist (47.37%), an IBD nurse (43.86%) and a coloproctologist (42.98%). The care provided by nurses and coloproctologists is more prevalent in patients with CD. The three categories cited as very important/important were: gastroenterologist (99.12%), coloproctologist (96.55%) and endoscopist (93.47%), in 4th position the nurse specialist in IBD (93.26%), in the 6th position the nutritionist (90.63%) and in 10th position the psychologist (84.61%). QoL was considered excellent or good in 45.61% of patients. Medication adherence was low in 58.88% of patients. Knowledge about the disease was low (6.21 ± 3.99 points), being higher among CD patients (p = 0.01). Conclusion: Patients considered doctors as the most important professionals in their care. Although the service has a multidisciplinary team, not all patients had the opportunity to consult with all professionals. The lack of contact with the entire team, especially with the nurse, may have contributed to low medication adherence and low knowledge of the disease, impacting disease control and QoL. Holistic patient care is recommended, emphasizing the importance of all professionals in multidisciplinary care for all patients with IBD.
- Published
- 2021
26. MILIARY TUBERCULOSIS AS A SEVERE ADVERSE REACTION TO THE USE OF ADALIMUMAB IN CROHN'S DISEASE: A CASE REPORT
- Author
-
Felipe Bertollo Ferreira, Vitor Lorencini Belloti, Bruna Barcellos Chaia, Marina Dadalto Scarpati, João Eugênio Loureiro Lopes, and Helena Demuner Vallandro
- Subjects
Miliary tuberculosis ,medicine.medical_specialty ,Crohn's disease ,Drug-Related Side Effects and Adverse Reactions ,business.industry ,Adalimumab ,General Medicine ,medicine.disease ,Dermatology ,medicine ,Tuberculosis ,business ,Adverse effect ,medicine.drug - Abstract
Introdução: A doença de Crohn é uma doença inflamatória intestinal (DII) que inicia um processo inflamatório crônico idiopático intestinal, levando a um quadro clínico variávelcujo principal sintoma é a diarreia crônica. O diagnóstico é feito a partir da combinação de dados clínicos, laboratoriais e exames endoscópicos. Após confirmado o diagnóstico, otratamento pode envolver classes medicamentosas como imunobiológicos. Em relação ao uso de imunobiológicos, como o adalimumabe, deve-se ter cautela pelo seu efeitoimunossupressor, que pode, em indivíduos susceptíveis, ativar focos latentes de infecção, como os de tuberculose (TB). Objetivo: Relatar um caso de tuberculose miliar como reação adversa ao uso de adalimumabe e conscientizar a comunidade médica quanto aos riscos da administração de terapia imunobiológica. Relato de caso: Paciente do sexo masculino, 31 anos, com diagnóstico de Doença de Crohn em acompanhamento ambulatorial com terapia imunobiológica com adalimumab, é admitido na emergência com quadro agudo de sintomas respiratórios e sistêmicos. Durante a investigação hospitalar, apesar de pesquisa do bacilo álcool- -ácido resistente (BAAR) no escarro ter apresentado três amostras negativas, a tomografia computadorizada (TC) de tórax apresentava padrão sugestivo de tuberculose miliar, além de um lavado broncoalveolar com pesquisa positiva para Mycobacterium tuberculosis. Confirmado o diagnóstico de TB miliar, o tratamento foi iniciado com rifampicina, isoniazida, pirazinamida e etambutol. Conclusão: Levando em consideração a alta mortalidade e os impactos negativos da tuberculose miliar, é imprescindível que todos os pacientes com DII em uso de imunobiológicos sejam rastreados para infecção latente, através da radiografia de tórax e teste tuberculínico (PPD). Entretanto, mesmo com o rastreio regular e registro de vacinação prévia, a possibilidade de tuberculose miliar ainda não pode ser descartada em quadros clínicos inespecíficos neste perfil de pacientes.Palavras chave: Adalimumab, Tuberculose, Efeitos colaterais e reações adversas relacionados a medicamentosABSTRACTIntroduction: Crohn’s disease is an inflammatory bowel disease (IBD) that initiates a chronic idiopathic intestinal inflammatory process, leading to a variety of clinical symptoms with chronic diarrhea as the main one. Diagnosis is built from a combination of clinical, laboratory and endoscopic data. The treatment involves immunobiological drugs, such as adalimumab and due to its immunosuppressive effect, it must be administered with caution, because it isable to activate latent foci of infection, such as tuberculosis (TB), in susceptible individuals. Objective: To report a miliary tuberculosis case originated as an adverse reaction to the use of adalimumab and to make the medical community aware of the risks of administering immunobiological therapy. Case report: A 31-year-old male, diagnosed with Crohn’s Disease, undergoing immunobiological treatment with adalimumab, is admitted in the emergency department with acute respiratory and systemic symptoms. During hospitalization, despite the investigation of alcohol-acid resistant bacillus (BAAR) in sputum showing three different samples with negative results, the computerized tomography (CT) of the chest showed a pattern suggestive of miliary tuberculosis, in addition to a bronchoalveolar lavage with a positive test for Mycobacterium tuberculosis. After the diagnosis of miliary TB was confirmed, treatment with rifampicin, isoniazid, pyrazinamide and ethambutol was started. Conclusion: Considering the high mortality and negative impacts of miliary tuberculosis, it is essentialthat all patients with IBD on immunobiological treatment are screened for latent infection through chest radiograph and PPD. However, even with regular screening and registration of previous vaccinations, the possibility of miliary tuberculosis cannot be ruled out in this profile of patients with unspecific clinical conditions.Keywords: Adalimumab, Tuberculosis, Drug-related side effects and adverse reactions Introduction: Crohn's disease is an inflammatory bowel disease (IBD) that initiates a chronic idiopathic intestinal inflammatory process, leading to a variable clinical manifestations whose chronic diarrhea main symptom is. Diagnosis is built from a combination of clinical, laboratory and endoscopic data. When diagnosed, treatment may involve drug classes such as immunobiologicals. Regarding the use of immunobiologicals, such as adalimumab, one should be cautious due to its immunosuppressive effect, able to, in susceptible individuals, activate latent foci of infection, such as tuberculosis (TB). Objective: To report a case of miliary tuberculosis as an adverse reaction to the use of adalimumab and to make the medical community aware of the risks of administering immunobiological therapy. Case report: A 31-year-old male patient diagnosed with Crohn's Disease under outpatient follow-up with adalimumab as immunobiological therapy is admitted to the emergency department with acute respiratory and systemic symptoms. During the hospital investigation, despite the investigation of alcohol-acid resistant bacillus (BAAR) in sputum, the computerized tomography (CT) of the chest showed a pattern suggestive of miliary tuberculosis, in addition to a bronchoalveolar lavage with a positive test for Mycobacterium tuberculosis. Once the diagnosis of miliary TB was confirmed, treatment was started with rifampicin, isoniazid, pyrazinamide and ethambutol. Conclusion: Taking into account the high mortality and negative impacts of miliary tuberculosis, it is essential that all patients with IBD using immunobiologicals are screened for latent infection through chest radiography and PPD. However, even with regular screening and registration of previous vaccinations, the possibility of miliary tuberculosis cannot be ruled out in nonspecific clinical conditions in this patient profile.
- Published
- 2021
27. La importancia de una nutrición adecuada para los pacientes con enfermedades inflamatorias del intestino y la mejora de la calidad de vida
- Author
-
Lima, Priscila Cardoso, Carvalho, Riane Loureiro Araújo de, Oliveira, Thayná Macêdo de, Freitas , Francisca Marta Nascimento de Oliveira, and Figueiredo, Rebeca Sakamoto
- Subjects
Quality of life ,Enfermedades inflamatorias del intestino ,Colite ulcerativa ,Doença de Crohn ,Calidad de vida ,Doenças inflamatórias intestinais ,Inflammatory bowel diseases ,Crohn's disease ,Nutritional therapy ,Ulcerative colitis ,Colitis ulcerosa ,Qualidade de vida ,Terapia nutricional ,Enfermedad de Crohn - Abstract
Introduction: The Inflammatory Bowel Disease (IBD) corresponds to a series of conditions that involve inflammation of the gastrointestinal tract, mainly in the intestine, becoming red, swollen and with the presence of ulcers. It is divided into two groups: Ulcerative Colitis and Crohn's Disease. Objective: To identify the importance of an adequate food strategy in promoting the quality of life of patients with Inflammatory Bowel Diseases, what are these diseases and their symptoms, what is the best nutritional strategy for patients with Inflammatory Bowel Diseases during treatment and to correlate the improvement in quality of life with the use of the nutritional strategy in patients with IBD. Methodology: The qualitative research method was used. Results and discussion: The IBD have treatments in the resources of medication, food, nutritional supplementation, conventional therapy and, in the last case, surgery to try to solve the improvement of symptoms in patients who do not respond to alternative treatments offered. Conclusion: The direct correlation of nutrition with the improvement in the quality of life of patients affected by inflammatory bowel diseases is still scarce, however, through the analysis of treatment with the multidisciplinary team, it is possible to observe a contribution to the stability of patients. Interdisciplinary care, the humanized and integral look of health professionals towards patients is necessary, as well as the development of new studies focused on the theme. Introducción: La Enfermedad Inflamatoria Intestinal (EII) corresponde a una serie de afecciones que involucran inflamación del tracto gastrointestinal, principalmente en el intestino, enrojeciéndose, inflamado y con presencia de úlceras. Se divide en dos grupos: colitis ulcerosa y enfermedad de Crohn. Objetivo: Identificar la importancia de una estrategia de alimentación adecuada en la promoción de la calidad de vida de los pacientes con Enfermedades Inflamatorias Intestinales, cuáles son estas enfermedades y sus síntomas, cuál es la mejor estrategia nutricional para los pacientes con Enfermedades Inflamatorias Intestinales durante el tratamiento y correlacionar la mejora de la calidad de vida con el uso de la estrategia nutricional en pacientes con EII. Metodología: Se utilizó el método de investigación cualitativa. Resultados y discusión: Las EII cuentan con tratamientos en los recursos de medicación, alimentación, complementación nutricional, terapia convencional y, en el último caso, cirugía para intentar solucionar la mejoría de los síntomas en los pacientes que no responden a los tratamientos alternativos ofrecidos. Conclusión: La correlación directa de la nutrición con la mejora en la calidad de vida de los pacientes afectados por enfermedades inflamatorias intestinales es aún escasa, sin embargo, a través del análisis del tratamiento con el equipo multidisciplinario, es posible observar un aporte a la estabilidad de los pacientes. . Es necesaria la atención interdisciplinaria, la mirada humanizada e integral de los profesionales de la salud hacia los pacientes, así como el desarrollo de nuevos estudios enfocados en la temática. Introdução: A Doença Inflamatória Intestinal (DII), corresponde a uma série de condições que envolvem a inflamação do trato gastrointestinal, principalmente no intestino, tornando-se vermelho, inchado e com presença de úlceras. Divide-se em dois grupos: Retocolite Ulcerosa e Doença de Crohn. Objetivo: Identificar a importância da estratégia alimentar adequada na promoção da qualidade de vida dos portadores de Doenças Inflamatórias Intestinais, quais são essas doenças e seus sintomas, qual a melhor estratégia nutricional para portadores de Doenças Inflamatórias Intestinais durante o tratamento e correlacionar a melhora da qualidade de vida com o uso da estratégia nutricional nos portadores de DII. Metodologia: Utilizou-se o método de pesquisa de caráter qualitativo. Resultados e discussão: As DII possuem tratamentos nos recursos de medicação, alimentação, suplementação nutricional, terapia convencional e em último caso, cirurgia para tentar solucionar a melhora dos sintomas em pacientes que não respondem às alternativas dos tratamentos oferecidos. Conclusão: A correlação direta da nutrição com a melhoria da qualidade de vida dos pacientes acometidos pelas doenças inflamatórias intestinais ainda possui escassez, porém, através das análises do tratamento com a equipe multidisciplinar é possível observar uma contribuição no quadro de estabilidade dos pacientes. O atendimento interdisciplinar, o olhar humanizado e integral dos profissionais da saúde para com os pacientes se faz necessário, assim como o desenvolvimento de novos estudos voltados para a temática.
- Published
- 2021
28. Arterite de Takayasu e doença de Crohn: uma associação incomum Takayasu's arteritis and Crohn's disease: an unusual association
- Author
-
Clóvis Konopka, Stela Karine Braun, and Gabriela Machado
- Subjects
Doença de Crohn ,doença de Takayasu ,arterite de Takayasu ,doença inflamatória intestinal ,Crohn's disease ,Takayasu's disease ,Takayasu's arteritis ,inflammatory bowel disease ,Surgery ,RD1-811 ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
A arterite de Takayasu e a doença de Crohn são doenças inflamatórias com etiologia desconhecida. Raramente ocorrem de modo concomitante em um mesmo indivíduo, havendo menos de 30 casos relatados na literatura. Este trabalho descreve essa associação em uma paciente de 36 anos de idade portadora de doença de Crohn, que apresentou redução dos pulsos no membro superior esquerdo e pressão arterial de 60/40 mmHg. A angiotomografia evidenciou estenose segmentar de artéria subclávia esquerda e espessamento parietal circunferencial da aorta na transição toracoabdominal entre T10 e L1, estabelecendo o diagnóstico de arterite de Takayasu. Ambas as patologias são mediadas imunologicamente e apresentam granulomas e vasculite granulomatosa, o que contribui para reforçar a hipótese de uma origem imunológica comum no seu desenvolvimento. Acreditamos que este seja o primeiro caso relatado na literatura brasileira da presença concomitante destas duas enfermidades.Takayasu's arteritis and Crohn's disease are chronic inflammatory diseases with unknown etiology. They rarely occur together in the same individual, with less than 30 cases reported in the literature. This case report describes this association in a 36-year-old woman with Crohn’s disease and weak pulses in her left arm with blood pressure of 60/40 mmHg. Angiotomography showed segmental stenosis in the left subclavian artery and circumferential thickening of the aortic wall between T10 and L1, establishing the diagnosis of Takayasu's arteritis. Both are organ-specific and immune-mediated diseases and exhibit granulomas and granulomatous vasculitis, which contribute to reinforce the hypothesis of a common immunologic origin. We believe that this is the first case of concomitant presence of these two diseases reported in the Brazilian literature.
- Published
- 2009
29. Manifestações articulares em pacientes com doença de Crohn e retocolite ulcerativa Articular manifestations in patients with Crohn's disease and ulcerative colitis
- Author
-
Cristina Costa Duarte Lanna, Maria de Lourdes Abreu Ferrari, Marco Antônio Parreiras de Carvalho, and Aloísio Sales da Cunha
- Subjects
artrite ,doença inflamatória intestinal ,espondiloartropatia ,doença de Crohn ,retocolite ulcerativa ,arthritis ,inflammatory bowel disease ,spondyloarthropathy ,Crohn's disease ,ulcerative colitis ,Diseases of the musculoskeletal system ,RC925-935 - Abstract
Os sintomas articulares constituem a manifestação extra-intestinal mais comum em pacientes com doença de Crohn e com retocolite ulcerativa. Reconhecida como artrite colítica, e mais recentemente, artrite enteropática, está classificada como uma das doenças do grupo das espondiloartropatias. Reconhecidamente, há dois padrões de acometimento articular: 1) periférico, habitualmente, associado aos períodos de atividade da doença intestinal e sem associação com o antígeno HLA B27, e 2) axial, caracterizado por espondilite e sacroiliíte, com curso clínico e radiográfico independente da doença intestinal e associado ao HLA B27.Joint involvement is the most commom extraintestinal manifestation in patients with Crohn's disease and ulcerative colitis. The colitic arthritis, lately called enteropathic arthritis, is classified as one of the diseases of the spondyloarthropathies group. There are two patterns of joint involvement: 1) peripheral arthritis, usually coincides with exacerbations of the inflammatory bowel disease and is not associated with the HLA B27 antigen; and 2) axial involvement, characterized by spondylitis and sacroiliitis, which the clinical course is independent of the intestinal disease, and has an association with HLA B27.
- Published
- 2006
- Full Text
- View/download PDF
30. Percepção da importância e adesão ao tratamento dietético de pacientes com doença inflamatória intestinal.
- Author
-
Henschel de Matos, Cristina, Lopes de Paulo, Anny Caroline, Ferreira de Souza de Carvalho, Samara, Imianovsky, Izabella, Imianowsky, Vanessa, Barretta, Claiza, and Grillo, Luciane Peter
- Abstract
Inflammatory bowel diseases (IBD), represented by Crohn's disease and ulcerative colitis, result in changes in food consumption and nutritional changes. This paper aimed to assess the perception of importance and compliance with diet therapy of patients with IBD. Sample was made up by patients of the IBD multidisciplinary clinic of a family and community health unit in the town of Itajaí, Santa Catarina state, Brazil. A semi-structured questionnaire was applied to patients with IBD, containing questions on personal data, quality of care provided, and their compliance with the nutritional guidelines provided in the care protocol given by the nutritionists. The patient's nutritional status was also evaluated, through anthropometric measurements and nutritional diagnosis at beginning of treatment and at the time of data collection. Statistical analyses were performed using the software STATA 13.0. Of the 56 patients interviewed, 98% considered it important to receive guidelines on food, and 93% said that their adhesion to the guidelines helped treating the disease. There was a prevalence of overweight patients, with 52% after follow-up with nutritional guidance, and reduction of malnutrition. Over 70% of patients said they had complied with the guidelines, and the average adherence to guidelines for BMI was 7.61 and for perception of aid it was 7.69. The guideline with highest adherence was "reducing consumption of fats" and the least adhered to was "consume only bean broth". Based on the results, we observed that patients recognize the importance of nutritional care and its importance in controlling symptoms, as well as the improvement in nutritional status and adhesion to most of the diet therapy guildelines. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
31. Panorama Geral Sobre Doenças Inflamatórias Intestinais: Imunidade e Suscetibilidade da Doença de Crohn e Colite Ulcerativa.
- Author
-
Ferraz, Francielle Bonet
- Subjects
- *
INFLAMMATORY bowel diseases , *CROHN'S disease , *ULCERATIVE colitis , *CYTOKINES , *IMMUNE response , *MEDICAL genetics , *DIAGNOSIS - Abstract
Inlammatory Bowel Diseases (IBD) are autoimmune diseases characterized by chronic inlammatory systemic diseases mainly related to the gastrointestinal tract. They are multifactorial diseases with varying prevalence and incidence according to genetics, environment, intestinal microbiota, or even an enteric infectious agent. Among the most common IBD, the Crohn' s Disease and Ulcerative Colitis stand out, with symptoms such as abdominal pain, fever, diarrhea, and vomiting, which can easily be confused with common gastroenteritis, thus making diagnosis dificult. The immune response in active IBD can be different in each type of the gastrointestinal pathology, being generally followed by a high concentration of proinlammatory cytokines in the lamina propria of the intestinal mucosa. Genetic, microbiological, and immunological variations may be due to disturbances in the tissues, which contribute to the pathophysiology of gastrointestinal disorders. IBD occurs between 15-25 or 50-80 years old, and the number of people affected has increased signiicantly in the south and southeast of Brazil. There is evidence that IBD are inherited; however, this is most frequently observed in patients with Crohn' s disease than in patients with ulcerative colitis. This review covers pertinent information about IBD, exemplifying the most common gastrointestinal pathologies, approaching immunological alterations, and discussing how the interbreeding of the two most common populations in the country in the early nineteenth century was able to determine different proiles and possible genetic susceptibility to diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
32. PERFIL CLÍNICO E ENDOSCÓPICO DE PACIENTES COM DOENÇA INFLAMATÓRIA INTESTINAL PROCEDENTES DE UMA POPULAÇÃO MISCIGENADA.
- Author
-
Cunha, Renata Fernandes, Domingues Cury, Pedro Vitor, Leite, Rafael Viana, Leite Leal, Leonardo Moreira, and Cavalcante, Lourianne Nascimento
- Abstract
Inflammatory bowel disease (IBD), Crohn's disease (CD) and ulcerative colitis (UC) are chronic diseases, potentially disabling and progressive. They have large impact on the lives of those affected, in general adults in the productive phase, leading real possibilities of complications and sequelae of great impact. Studies in epidemiology are of great importance for facilitating the identification of the most prevalent areas for adequate investment in health. The purpose is trace the clinical and endoscopic profile of patients followed in reference clinics in these diseases in the state of Bahia. Cross-sectional study which covered 105 patients with IBD treated atreference clinical units in the State of Bahia, encompassing retrospective analysis of medical records to obtain socio demographic data, analysis of the current and past history of the illness through information contained in laboratory and endoscopic exam. Such data were classified according to location criteria and activities through the Montreal indexes, Truelove & Witts, Mayo, HBI (Harvey- Bradshaw index), and the quality of life analysis by IBD Questionnaire (IBDQ), ending with exploratory data analysis. 105 analyzed patients - 38 male and 76 female, the diagnosis of ulcerative colitis was observed in 60 individuals, mostly women (66.7 %), 45 patients had diagnosis of CD, also with a female majority at 60, 0 % (p = 0.482). The average age of the sample is 39.6 years ranging from 18 to 88 years, already self-classification of race, based on skin color, revealed 38 black, 50 mullatos and 17 white people. Predominance of the diagnosis of ulcerative colitis compared to DC, especially in patients in the age range of young adult female, in both Crohn's Disease or Ulcerative Colitis, self-classified as mulatto. The dominant behavior on DC was, not stenotic and non-penetrating, with most patients in remission. In the group with RCU the most common location was the left colitis with a predominance of hyperemia/anantema/edema with mild clinical activity. By IBDQ it was noted that with the improvement of clinical activity, the highest score is observed. The current treatment follows the recommendations in the literature with the use of immunosuppressants, aminosalicylates, corticosteroids and biological therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2016
33. IMPACTO DA PORPHYROMONAS GINGIVALIS NA DOENÇA INFLAMATÓRIA INTESTINAL: UMA REVISÃO DE LITERATURA.
- Author
-
Carvalho Leal, Osmaria Letthycia, de Oliveira Braz, Ana Valéria, Carvalho Rodrigues, Mariana, and Silva Tavares, Samia Jéssica
- Subjects
- *
INFLAMMATORY bowel diseases , *CROHN'S disease , *ULCERATIVE colitis , *LITERATURE reviews , *PORPHYROMONAS gingivalis - Abstract
This article is a literature review that analyzes the impact of Porphyromonas gingivalis (Pg) on inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. Through the review of clinical and non-clinical studies, it was observed that Pg is related to the development and exacerbation of IBD, increasing inflammatory markers such as TNF-α, IL-1β, and IL-6, and disrupting Th17/regulatory T cell balance. However, one study reported that Pg may protect the gastrointestinal tract. Further research is needed to better understand the correlation between periodontitis and IBD. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
34. Structuring and validation of the nursing consultation for patients with Inflammatory Bowel Disease
- Author
-
Barros, Jaqueline Ribeiro de [UNESP], Universidade Estadual Paulista (Unesp), and Sassaki, Ligia Yukie [UNESP]
- Subjects
Crohn's disease ,Nursing consultation ,Colite ulcerativa ,Ulcerative colitis ,Doença de Crohn ,Consulta de Enfermagem ,Nursing care ,Cuidados de enfermagem ,Doenças inflamatórias intestinais ,Inflammatory bowel diseases - Abstract
Submitted by Jaqueline Ribeiro de Barros (jaqueline.barros@unesp.br) on 2021-04-13T12:55:13Z No. of bitstreams: 1 Tese pós defesa 2 - 04 04 2021 - Jaqueline Ribeiro Barros.pdf: 1582491 bytes, checksum: e079efa4d4cc91802cfd286c5c07054f (MD5) Rejected by ROSANGELA APARECIDA LOBO null (rosangelalobo@btu.unesp.br), reason: Solicitamos que realize uma nova submissão seguindo as orientações abaixo: Problema 1: financiamento Capes No formulário de submissão consta a Capes como agência financiadora do seu projeto. No arquivo submetido não localizei uma agradecimento a esta. Isso é uma exigência das agências de fomento. E a Capes sugere que o agradecimento seja feito da seguinte maneira: "O presente trabalho foi realizado com apoio da Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Código de Financiamento 001 Assim que tiver efetuado a correção submeta o arquivo, em formato PDF, novamente. Agradecemos a compreensão. on 2021-04-15T12:46:37Z (GMT) Submitted by Jaqueline Ribeiro de Barros (jaqueline.barros@unesp.br) on 2021-04-17T17:08:50Z No. of bitstreams: 1 Tese pós defesa 5.pdf: 2355052 bytes, checksum: 2ab6300a9fc2768471693bcabea54fab (MD5) Approved for entry into archive by ROSANGELA APARECIDA LOBO null (rosangelalobo@btu.unesp.br) on 2021-04-19T14:35:47Z (GMT) No. of bitstreams: 1 barros_jr_dr_bot.pdf: 2355052 bytes, checksum: 2ab6300a9fc2768471693bcabea54fab (MD5) Made available in DSpace on 2021-04-19T14:35:47Z (GMT). No. of bitstreams: 1 barros_jr_dr_bot.pdf: 2355052 bytes, checksum: 2ab6300a9fc2768471693bcabea54fab (MD5) Previous issue date: 2021-02-26 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Introdução: A doença inflamatória intestinal (DII) cursa com sintomas incapacitantes levando a impacto significativo na qualidade de vida e na capacidade funcional dos pacientes. Devido à complexidade da doença e às peculiaridades do tratamento, o acompanhamento deve ser realizado por equipe multidisciplinar, incluindo o enfermeiro. A assistência de enfermagem deve ser baseada em protocolos assistenciais validados para que a abordagem seja sistematizada. No Brasil, não há protocolos de assistência de enfermagem validados para atendimento aos pacientes com DII. Objetivo: Construir instrumento de consulta de enfermagem e validar o conteúdo do protocolo assistencial para pacientes com DII. Métodos: Foi desenvolvido um estudo transversal, descritivo, com abordagem quantitativa. O estudo foi conduzido de junho de 2018 à janeiro de 2021 por meio eletrônico. Foram convidados para participar do estudo, enfermeiros assistenciais, supervisores e/ou docentes que trabalham em instituições públicas e privadas de assistência à saúde. A validação da consulta de enfermagem através da concordância entre as respostas dos enfermeiros experts. A técnica Delphi foi a metodologia selecionada para a obtenção do consenso dos enfermeiros experts. Análise estatística: a análise descritiva foi realizada para cada um dos os itens da consulta de enfermagem por meio de frequências simples e percentuais quando categóricas. Resultados: Foram identificados 345 enfermeiros; 32 foram elegíveis como experts, e 13 realizaram a validação do instrumento. A maioria dos enfermeiros era do sexo feminino (11, 84,62%); idade média de 46,36±10,59 anos; 8 (61,54%) enfermeiros graduaram-se em instituições públicas; 8 (61,54%) cursaram mestrado. O instrumento inicial continha 106 itens e foi finalizado com 95. Quatros domínios (identificação; perfil saúde-doença; necessidades psicobiológicas e exame físico) foram validados em 2 rodadas em relação ao conteúdo e 2 domínios (dados sociodemográficos e condições de saúde e cuidados pessoais) na primeira rodada. Todos os domínios foram validados em relação a aparência na primeira rodada. Conclusão: A consulta de enfermagem apresentou nível de concordância considerável para validação de conteúdo e aparência em todas as dimensões. Introduction: Inflammatory bowel disease is associated with disabling symptoms leading to a significant impact on patients’ quality of life and functional capacity. Due to the complexity of the disease and the peculiarities of the treatment, monitoring must be performed by a multidisciplinary team, including the nurse. Nursing care must be based on validated care protocols so that the approach is systematized. In Brazil, there are no validated nursing care protocols for the care of patients with inflammatory bowel disease. Objective: To construct a nursing consultation instrument and validate the content of the care protocol for patients with inflammatory bowel disease. Methods: A cross-sectional, descriptive study with quantitative approach was developed. The study was conducted from June 2018 to January 2021 electronically. Assistance nurses, supervisors and or teachers working in public and private health care institutions were invited to participate in the study. The consultation was validated through the agreement between the answers of the expert nurses. The Delphi technique was the methodology selected to obtain the consensus of the expert nurses. Statistical analysis: Descriptive analysis was performed for each of the nursing consultation items by means of simple and percentage frequencies when categorical. Results: A total of 345 nurses were identified; where 32 were eligible as experts, however only 13 agreed to proceed with the research. Most nurses were female (11, 84.62%); mean age 46.36±10.59 years; 8 (61.54%) nurses graduated from public institutions; 8 (61.54%) attended a master's degree. The initial instrument contained 106 items and was finished with 95. Four domains (identification; health-disease profile; psychobiological needs and physical examination) were validated in 2 rounds in relation to content and 2 domains (sociodemographic data and health conditions and personal care) in the first round. All domains were validated in relation to appearance in the first round. Conclusion: The nursing consultation showed a considerable level of agreement for content and appearance validation in all dimensions CAPES: 001
- Published
- 2021
35. Clinical features and outcomes of very-early-onset inflammatory bowel disease in brazilian children
- Author
-
Penatti, Debora Avellaneda, Universidade Estadual Paulista (Unesp), Rodrigues, Maria Aparecida Marchesan [UNESP], Machado, Nilton Carlos [UNESP], and Carvalho, Mary de Assis [UNESP]
- Subjects
Lactente ,Crohn's disease ,Neonate ,Doença de Crohn ,Idade de início ,Ulcerative Colitis ,Infant ,Criança ,Age of Onset ,Neonato ,Child ,Retocolite Ulcerativa - Abstract
Submitted by Débora Avellaneda Penatti (debora.penatti@unesp.br) on 2020-12-15T20:00:09Z No. of bitstreams: 1 IBD pdf defesa da Tese FINALissima com cep ficha catalografica sem paginas em branco word .pdf: 4827531 bytes, checksum: ec2c29f53d75e2e9bda76712f5f0f640 (MD5) Approved for entry into archive by Tais de Almeida (tais.almeida@unesp.br) on 2020-12-16T19:38:54Z (GMT) No. of bitstreams: 1 penatti_da_dr_bot.pdf: 4827531 bytes, checksum: ec2c29f53d75e2e9bda76712f5f0f640 (MD5) Made available in DSpace on 2020-12-16T19:38:54Z (GMT). No. of bitstreams: 1 penatti_da_dr_bot.pdf: 4827531 bytes, checksum: ec2c29f53d75e2e9bda76712f5f0f640 (MD5) Previous issue date: 2020-11-20 Introdução: A doença inflamatória intestinal de início muito precoce na infância (DII-VEO) é uma entidade rara, agressiva, de difícil controle, que ocorre em crianças menores de 6 anos. O diagnóstico correto e o tratamento adequado são importantes para prevenir complicações. Objetivo: Analisar as características clinico-patológicas e a evolução de todas as crianças com diagnóstico de DII-VEO, atendidas no serviço de Gastroenterologia Pediátrica da Faculdade de Medicina de Botucatu- Unesp. Métodos: Foram analisados retrospectivamente 20 casos de crianças com diagnóstico de DII-VEO. A casuística compreendeu 13 crianças com características clínico patológicas de retocolite ulcerativa (RCU) e 7 crianças com doença de Crohn (DC). Foram feitas comparações entre os grupos quanto aos dados clínicos, demográficos, antropométricos, laboratoriais, colonoscópicos e histopatológicos. Resultados: A mediana de idade do grupo RCU foi 48 meses e do grupo DC 14 meses. Houve predomínio de meninas (17/20). O grupo DC apresentou maior comprometimento do peso e estatura quando comparado ao grupo RCU. Diarreia e sangue nas fezes foram os sintomas mais prevalentes em ambos os grupos. Doença perianal foi identificada em todos os casos do grupo DC. Anemia, aumento do PCR e hipoalbuminemia foram mais intensos no grupo DC do que no grupo RCU, necessitando maior intervenção nutricional, como terapia nutricional enteral e tratamento mais agressivo. O grupo DC apresentou maior número de complicações, como linfoma (2/7), colectomia total (1/7) e óbitos (2/7). Histologicamente houve diferença significativa entre o grupo RCU e o grupo DC. Inflamação com presença de plasmocitose, microabscessos de criptas e distorção arquitetural das criptas foram características do grupo RCU. Inflamação focal, presença de granulomas e ausência de distorção de criptas foram características das biópsias do grupo DC. Conclusão: É possível elaborar o diagnóstico correto de doença inflamatória intestinal de início muito precoce na infância (DII-VEO) em centros especializados de Gastroenterologia Pediátrica no Brasil. Nosso estudo demonstrou que é possível fazer o acompanhamento clínico adequado e obter resultados satisfatórios, seguindo as diretrizes internacionais de conduta terapêutica para esta entidade. Background: Very early onset Inflammatory Bowel Disease is a rare, aggressive and difficult entity. Accurate diagnosis and appropriate treatment are essential to prevent complications. Objective: To evaluate the clinicopathological features and outcomes of early-onset inflammatory bowel disease in a cohort of Brazilian children. Methods: A series of 20 cases of children under six years of age diagnosed with Very Early Onset Inflammatory Bowel Disease (IBD-VEO) between 2005 and 2018 were reviewed. The sample comprised 13 children with ulcerative colitis (RCU) and seven children with Crohn's disease (CD). Comparisons were made between these two groups regarding clinical-demographic characteristics, anthropometric, laboratory, colonoscopic and histopathological parameters. Results: The median age of the RCU group was 48 months, and the DC group was 14 months. The DC group presented more significant impairment of weight and height when compared to the RCU group. Diarrhoea and blood in the stools were the most common symptoms in both groups. The perianal disease was identified only in the DC group. Anaemia, increased C-reactive protein and hypoalbuminemia were more intense in children with DC than the RCU group. The CD group presented younger and more severe children concerning children with RCU, requiring more significant nutritional intervention such as enteral nutritional therapy and more aggressive treatment with intravenous corticosteroids. In the CD group, there were two deaths and two patients with large cell lymphoma. Histologically there was a significant difference between the RCU and DC groups. Inflammation with plasmacytosis, crypts microabscesses and crypts architectural distortion were characteristic of RCU children. Focal inflammation, presence of granulomas and absence of crypt distortion were features of CD children. Conclusion: A correct diagnosis of early inflammatory bowel disease (IBD-IBD) can be established in specialized pediatric gastroenterology centres in Brazil. Our study demonstrated that it is possible to adequately monitor children with this disease and obtain satisfactory results, following the international guidelines for therapeutic management of this disease.
- Published
- 2020
36. Prebióticos y probióticos en salud y en el tratamiento de enfermedades intestinales: una revisión integrativa
- Author
-
Marques, Chayane Gomes, Cruz, Edna Milene Ribeiro Maia da, Bezerra, Valéria Mendes, Costa, Joana Talita Galdino, Lira, Sandra Machado, Holanda, Marcelo Oliveira, Silva, José Ytalo Gomes da, Canabrava, Natália do Vale, Silva, Bruno Bezerra da, and Guedes, Maria Izabel Florindo
- Subjects
Prebióticos ,Constipação ,Frío ,Doença de Crohn ,Síndrome do intestino irritável ,Probiotics ,Probióticos ,Salud ,Irritable bowel syndrome ,Saúde ,Enfermedades intestinales ,Doenças intestinais ,Retocolite ulcerativa ,Crohn's disease ,Prebiotics ,Ulcerative colitis ,Colitis ulcerosa ,Health ,Enfermedad de Crohn ,Intestinal diseases ,Síndrome del intestino irritable ,Constipation - Abstract
Objective: to carry out an integrative review on the role of prebiotics and probiotics in maintaining health, as well as their applications in the treatment of chronic idiopathic constipation (CIC), irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Methodology: this is an integrative literature review, whose search for studies was carried out in the Cochrane and PubMed databases, with analysis of studies published in the last ten years (2010-2020) written in English. Results: The use of probiotics in CIC and IBS has shown beneficial effects in reducing the symptoms of these diseases, modifying the microbiota and improving the quality of life of patients. In CIC, inulin was the prebiotic with the most positive effects on the symptoms of the disease. In IBD, the use of prebiotics and probiotics showed slightly greater beneficial effects for UC than for CD. Conclusion: Prebiotics and probiotics can bring both preventive and therapeutic benefits to intestinal health, with direct and indirect actions on the microbiota, immunity and metabolic processes of the host. The use of these compounds and microorganisms in the studied diseases show promising results, mainly in the field of probiotics. From the analysis of clinical trials, the promising strains in the treatment of IBD were Bifidobacterium, Lactobacillus, Enterococcus faecium (DC and RCU) and Clostridium butyricum (RCU). However, we emphasize the need for more homogeneous studies in the treatment of CD with probiotics and prebiotics and the use of prebiotics in IBS. Objetivo: realizar una revisión integradora sobre el papel de los prebióticos y probióticos en el mantenimiento de la salud, así como sus aplicaciones en el tratamiento del estreñimiento idiopático crónico (CIC), síndrome del intestino irritable (SII) y enfermedad inflamatoria intestinal (EII). Metodología: se trata de una revisión integradora, cuya búsqueda de estudios se realizó en las bases de datos Cochrane y PubMed, con análisis de estudios publicados en los últimos diez años (2010-2020) escritos en inglés. Resultados: El uso de probióticos en CIC e SII ha mostrado efectos beneficiosos en la reducción de los síntomas de estas enfermedades, modificando la microbiota y mejorando la calidad de vida de los pacientes. En CIC, la inulina fue el prebiótico con más efectos positivos sobre los síntomas de la enfermedad. En la EII, el uso de prebióticos y probióticos mostró efectos beneficiosos ligeramente mayores para la CU que para la EC. Conclusión: Los prebióticos y probióticos pueden aportar beneficios tanto preventivos como terapéuticos a la salud intestinal, con acciones directas e indirectas sobre la microbiota, la inmunidad y los procesos metabólicos del huésped. El uso de estos compuestos y microorganismos en las enfermedades estudiadas muestra resultados prometedores, principalmente en el campo de los probióticos. Las cepas prometedoras en el tratamiento de la EII fueron Bifidobacterium, Lactobacillus, Enterococcus faecium (EC y CU) y Clostridium butyricum (CU). Sin embargo, destacamos la necesidad de estudios más homogéneos en el tratamiento de la EC con probióticos y prebióticos y el uso de prebióticos en el SII. Objetivo: realizar uma revisão integrativa sobre a função dos prebióticos e probióticos na manutenção da saúde, bem como suas aplicações no tratamento da constipação idiopática crônica (CIC), da síndrome do intestino irritável (SII) e da doença inflamatória intestinal (DII). Metodologia: trata-se de uma revisão integrativa da literatura, cuja busca dos estudos foi realizada nas bases de dados Cochrane e PubMed, com análise de trabalhos publicados nos últimos dez anos (2010-2020) escritos em inglês. Resultados: O uso de probióticos na CIC e SII mostrou efeitos benéficos na redução dos sintomas dessas doenças, modificação na microbiota e melhora na qualidade de vida dos pacientes. Na CIC, a inulina foi o prebiótico com mais efeitos positivos na sintomatologia da doença. Na DII, o uso de prebióticos e probióticos mostrou efeitos benéficos discretamente maiores para a RCU do que para a DC. Conclusão: Prebióticos e probióticos podem trazer tanto benefícios preventivos quanto terapêuticos à saúde intestinal, com ações diretas e indiretas na microbiota, imunidade e processos metabólicos do hospedeiro. A utilização desses compostos e microrganismos nas doenças estudadas demonstram resultados promitentes, principalmente, no campo dos probióticos. A partir da análise dos ensaios clínicos, as cepas promissoras no tratamento da DII foram Bifidobacterium, Lactobacillus, Enterococcus faecium (DC e RCU) e Clostridium butyricum (RCU). No entanto, salientamos a necessidade de estudos mais homogêneos no tratamento da DC com probióticos e prebióticos e o uso de prebióticos na SII.
- Published
- 2020
37. Prevalência e fatores associados ao supercrescimento bacteriano do intestino delgado em pacientes com doença de Crohn: estudo retrospectivo em um centro de referência
- Author
-
Bertges, Erika Ruback, Chebli, Júlio Maria Fonseca, Chebli, Liliana Andrade, and Penna, Francisco Guilherme Cancela e
- Subjects
Crohn’s disease ,CIENCIAS DA SAUDE [CNPQ] ,Fatores de risco ,Risk factors ,Doença de Crohn ,Prevalence ,Prevalência ,Doença inflamatória intestinal ,Small intestinal bacterial overgrowth ,Supercrescimento bacteriano do intestino delgado ,Inflammatory bowel disease - Abstract
O supercrescimento bacteriano de intestino delgado (SBID) parece ser comum em pacientes com doença de Crohn (DC). A taxa de SBID tem sido estimada entre 15 a 45% neste cenário. Entretanto, diferenças demográficas, socioeconômicas e dos fatores relacionados à doença podem existir entre as populações da América do Sul e da América do Norte ou da Europa que podem limitar a generalização destes achados, uma vez que os dados são derivados principalmente de estudos norte-americanos ou europeus. Dessa forma, objetivamos estudar a prevalência e os preditores de SBID em pacientes ambulatoriais com DC e, paral tal, realizamos um estudo retrospectivo em que avaliamos os registros médicos eletrônicos de 110 pacientes com DC que haviam sido submetidos ao teste respiratório do hidrogênio e metano expirados para o diagnóstico de SBID, entre junho de 2011 e junho de 2016. Análise univariada foi realizada para investigar a potencial associação entre SBID e dados demográficos, relacionados à DC e marcadores sistêmicos de inflamação (proteína C-reativa e velocidade de hemossedimentação). Observamos que a prevalência de SBID foi elevada em pacientes com DC (30%). Os pacientes com e sem SBID foram comparáveis de acordo com os dados demográficos e de biomarcadores de inflamação sistêmica, bem como das características da DC, exceto pelo fenótipo estenosante, mais comum nos pacientes com DC e SBID (48.5% vs. 19.5%, p=0,002). A partir desses achados, concluímos que em pacientes brasileiros com DC, SBID é uma condição altamente prevalente. O fenótipo estenosante demonstrou forte associação com o SBID. O planejamento de um screening individualizado seguido por tratamento apropriado para SBID deve ser incluído como parte da melhoria na qualidade de cuidados a ser oferecida para os pacientes com DC. Small intestinal bacterial overgrowth (SIBO) appears to be common in patients with Crohn’s disease (CD). The rate of SIBO has been estimated at 15 a 45% in this setting. However, different demographic, socioeconomic, and disease-related factors may exist between South American and North American or European populations that may limit the generalization of these findings, as the data are mainly derived from North American or European studies. We studied the prevalence and predictors of SIBO in CD outpatients. In this retrospective study, between june 2011 and june 2016, the medical records of 110 CD patients were assessed for presence of SIBO using the H2/CH4 glucose breath test. Univariate analysis was performed to investigate the potential association between SIBO and demographic, disease-related data, systemic markers of inflammation (C-reactive protein and erythrocyte sedimentation rate). Our resuls were that SIBO rate was high in CD patients (30%). Patients with and without SIBO were comparable according to demographics, systemic inflammatory biomarkers, and disease characteristics, except to the stricturing phenotype more common in the SIBO-positive CD patients (48.5% vs. 19.5%, p=0.002). From these findings, we conclude that in brazilian CD patients, SIBO is a highly prevalent condition. Stricturing phenotype demonstrated association with SIBO. An individualized screening plan followed by the timely treatment for SIBO should be carried out as part of quality of care improvement in CD individuals.
- Published
- 2020
38. Internship and Monograph reports entitled'Biological therapeutics for Crohn's disease and the role of the pharmacist'
- Author
-
Domingues, Ana Teresa Afonso, Gama, Cláudia Maria Branco da, Silva, Elisa Maria Carvalho Rasteiro, and Lage, João Carlos Canotilho
- Subjects
Monoclonal antibody ,Inflammation ,Inflamação ,Cronicidade ,Crohn's disease ,Doença de Crohn ,Anticorpo monoclonal ,Chronicity ,Pharmacist ,Farmacêutico - Abstract
Relatório de Estágio do Mestrado Integrado em Ciências Farmacêuticas apresentado à Faculdade de Farmácia A Doença de Crohn evidencia-se como uma patologia extremamente complexa. Manifesta-se, sobretudo, no sistema gastrointestinal sob a forma de inflamação, mas, em alguns casos, difunde-se noutros locais do organismo. Atualmente, já se conhecem vários mecanismos patológicos capazes de desencadear a cronicidade da doença, porém muitos permanecem desconhecidos e outros já estão a ser alvo de estudos. Fatores ambientais, genéticos e imunológicos concorrem para a sua génese. Assim, classifica-se esta patologia como crónica, idiopática e multifatorial.Os doentes devem ser alertados para a existência de fatores de risco que contribuem para o agravamento da sua situação e, nessa área, o farmacêutico representa um papel de extrema importância por ser, muitas vezes, o primeiro profissional de saúde a que os doentes se dirigem. O objetivo da terapêutica convencional consiste na indução da remissão da doença e na sua manutenção, ainda que nem todos os fármacos disponíveis permitam atingir essas finalidades. A terapêutica instituída depende de vários fatores e difere se estivermos perante uma doença leve ou severa. O farmacêutico deve salientar a importância de manter uma dieta adequada às exigências e de fazer suplementação para suprir as carências que a toma de alguns destes medicamentos podem provocar. As terapêuticas mais avançadas que estão, atualmente, instauradas consistem nos medicamentos biológicos, mais concretamente nos anticorpos monoclonais. O seu uso resultou, indubitavelmente, em melhores respostas terapêuticas e numa menor necessidade de cirurgia. A sua maior vantagem reside no facto de os seus mecanismos serem direcionados a várias vias patológicas, o que permite que sejam uma opção para um maior número de doentes. Por esta razão e outras, neste momento, os fármacos biológicos constituem a classe preferida ao tratamento da doença moderada a severa.Numa doença de gestão tão exigente como esta, as perspetivas futuras representam, sempre, uma enorme esperança de chegar ao maior número de doentes possível, o que, neste caso, se torna mais difícil pela enorme variedade de fenótipos que existe. A natureza imprevisível e progressiva desta doença tem motivado o estudo mais aprofundado da sua fisiopatologia, o que tem permitido chegar, também, a moléculas promissoras para os alvos terapêuticos encontrados. Crohn's disease is an extremely complex pathology. It manifests itself mainly in the gastrointestinal system in the form of inflammation, but, in some cases, it spreads elsewhere in the body. Currently, several pathological mechanisms are known to trigger the chronicity of the disease, however many of them remain unknown and others are already being studied. Environmental, genetic and immunological factors contribute to its genesis. Therefore, this pathology is classified as chronic, idiopathic and multifactorial.Patients should be alerted to the risk factors that contribute to the worsening of their situation and, in this area, the pharmacist plays an extremely important role as he is often the first health professional to whom patients resort to.The aim of conventional therapy is to induce remission of the disease and to maintain it, although not all available drugs can achieve these purposes. The chosen therapy depends on several factors and differs if we are facing a mild or severe disease. The pharmacist must emphasize the importance of maintaining a diet that is adequate to the requirements and supplementing to supply the deficiencies that some of these medications can cause.The most advanced therapies that are available consist of biological drugs, more specifically monoclonal antibodies. Its use has, undoubtedly, resulted in better therapeutic responses and less need for surgery. Its greatest advantage is based on the fact that its mechanisms are directed to various pathological pathways, so they are an option for a greater number of patients. For this reason, biological drugs are, currently, the preferred class for the treatment of moderate to severe disease.In a disease whose management is as demanding as this, future perspectives represent an enormous hope of reaching the largest number of patients, which, in this case, it becomes more complicated by the enormous variety of phenotypes that exist. The unpredictable and progressive nature of this disease has motivated the further study of its pathophysiology, which has also allowed it to reach promising molecules to the therapeutic targets found.
- Published
- 2020
39. Doença granulomatosa orofacial associada a Doença de Crohn – uma revisão narrativa
- Author
-
Dias, Ana Margarida Batista and Assunção, Amélia
- Subjects
Crohn’s disease ,Doença de Crohn ,Ciências Médicas::Medicina Clínica [Domínio/Área Científica] ,Oral inflammation ,Oral pathology ,Inflamação oral ,Doença granulomatosa orofacial ,Patologia oral ,Orofacial granulomatosis disease - Abstract
Submitted by azevedo@ufp.pt (azevedo@ufp.pt) on 2021-02-10T10:59:52Z No. of bitstreams: 1 PPG_33680.pdf: 382873 bytes, checksum: e81101af2b8572aac20a87acf41236e1 (MD5) Approved for entry into archive by azevedo@ufp.pt (azevedo@ufp.pt) on 2021-02-10T11:01:19Z (GMT) No. of bitstreams: 1 PPG_33680.pdf: 382873 bytes, checksum: e81101af2b8572aac20a87acf41236e1 (MD5) Made available in DSpace on 2021-02-10T11:01:19Z (GMT). No. of bitstreams: 1 PPG_33680.pdf: 382873 bytes, checksum: e81101af2b8572aac20a87acf41236e1 (MD5) Previous issue date: 2020-07-23
- Published
- 2020
40. A study on systems based on Fuzzy rules
- Author
-
Silva, André Luigi da and Peixoto, Magda da Silva
- Subjects
Crohn’s disease ,Fuzzy sets ,Doença de Crohn ,Fuzzy system ,MATEMATICA::MATEMATICA APLICADA [CIENCIAS EXATAS E DA TERRA] ,Sistemas Fuzzy ,Índice de Harvey-Bradshaw ,Conjuntos Fuzzy ,The Harvey-Bradshaw index - Abstract
Não recebi financiamento The practice of medicine is an analytical and uninterrupted decision-making process in which the variables involved are often subjective (i.e. not measurable) so Fuzzy Logic is a very participative resource in the decision-making process. Within this scenario, this research aims to conduct a study of concepts that use the Fuzzy Theory and suggests a model that measures the activity of an inflammatory bowel disease. Crohn’s disease, among other indexes, has an activity meter known as the Harvey-Bradshaw index for which a fuzzy model will be proposed and relate the accentuation of symptoms to the stage of the disease. A exercício da medicina é um processo analítico e ininterrupto de tomadas de decisões no qual frequentemente as variáveis envolvidas são subjetivas, isto é, não mensuráveis, dessa forma a Lógica Fuzzy é um recurso muito participativo no processo decisório. Dentro deste cenário, esta pesquisa tem como objetivo realizar um estudo de conceitos que fundamentam a Teoria dos Conjuntos Fuzzy e sugere um modelo que mensura a atividade de uma doença intestinal inflamatória. A Doença de Crohn, entre outros índices, possui um medidor de atividade conhecido como índice de Harvey-Bradshaw, para o qual será apresentado um modelo fuzzy que relaciona a acentuação dos sintomas com a fase da doença.
- Published
- 2020
41. Influência das crenças religiosas/espirituais na remissão, qualidade de vida e saúde mental de pacientes com doença de Crohn ativa: estudo longitudinal de dois anos de seguimento
- Author
-
Campos, Renata Jacob Daniel Salomão de, Chebli, Júlio Maria Fonseca, Lucchetti, Giancarlo, Zanini, Karine Andrade Oliveira, Lucchett, Alessandra Lamas Granero, Bertges, Luiz Carlos, and Goncalves, Jurema Ribeiro Luiz
- Subjects
Quality of life ,Qualidade de vida ,Crohn's disease ,Espiritualidade ,CIENCIAS DA SAUDE [CNPQ] ,Doença de Crohn ,Religião e medicina ,Spirituality ,Mental health ,Doenças Inflamatórias Intestinais ,Inflammatory bowel diseases ,Saúde mental ,Religion and medicine - Published
- 2020
42. Fatores associados a necessidade de otimização de dose de infliximabe em paciente com doença de Crohn
- Author
-
Petry, Roberta Cristina and Flores, Cristina
- Subjects
Crohn's disease ,Fatores de risco ,Doença de Crohn ,Dosagem ,Relação dose-resposta a droga ,Loss of response ,Infliximab ,Dose optimization - Abstract
Introdução: A terapia biológica revolucionou o tratamento das doenças inflamatórias intestinais (DII) aumentando os índices de remissão de doença. Apesar disso, uma porcentagem significativa dos pacientes pode apresentar resposta parcial ou perda de resposta com o passar do tempo. Tais pacientes necessitam de otimização terapêutica, seja por aumento da dose ou redução do intervalo entre as infusões. Objetivos: Identificar os possíveis fatores relacionados a necessidade de otimização de dose de Infliximabe (IFX) em pacientes com Doença de Crohn (DC). Método: Foi conduzida uma coorte retrospectiva com segmento prospectivo, incluindo pacientes com diagnóstico de DC em acompanhamento no Centro de infusões do Hospital Dia do Hospital de Clínicas de Porto Alegre (HCPA). Foram coletados, através de revisão de prontuário e entrevista com o paciente, dados demográficos, variáveis clínicas, laboratoriais, endoscópicas e radiológicas em quatro momentos: no diagnóstico, na indicação do IFX, na semana 14 de tratamento e ao final de 1 ano de tratamento. Resultados: Foram avaliados 121 pacientes. Destes, 58 (47,93%), foram submetidos a otimização da dose de IFX. Ao avaliar se os fatores de pior prognóstico epidemiológicos, clínicos, laboratoriais e endoscópicos se relacionavam com a necessidade de otimização, observou-se diferença estatisticamente significativa entre os grupos (otimizados e não otimizados) em relação a anemia (p=0.019) e manutenção da elevação de proteína C reativa (PCR) na semana 14 (p=0.039). Após o ajuste pelo modelo multivariado apenas a manutenção da elevação da PCR na semana14 2 permaneceu estatisticamente significativa, com risco 119% maior de otimizar o tratamento quando comparados àqueles com PCR normal. Conclusão: Dentre todos os fatores analisados, apenas a manutenção da elevação de PCR acima do limite de normalidade na semana 14 foi associado à necessidade de otimização de dose de IFX. Isso é condizente com a literatura que descreve a semana 14 como um momento ideal de avaliação dos níveis sérico de imunobiológico como preditor de resposta sustentada. Assim, num contexto de saúde pública e na indisponibilidade de dosagem sérica, este marcador inflamatório sérico poderia auxiliar de uma forma fácil e barata a decisão terapêutica. Introduction: Biological therapy has revolutionized the treatment of inflammatory bowel diseases (IBD) by increasing disease remission rates. Despite this, a significant amount of patients may experience partial response or loss of response over time. Such patients need optimization of therapy, either by increasing the dose or reducing the interval between infusions. Objectives: To identify possible factors related to the need for infliximab (IFX) optimization in patients with Crohn's disease (CD). Method: Retrospective and prospective maintained database of CD patients under IFX treatment being followed up in the Infusion Center at the Day Hospital of the Hospital de Clínicas de Porto Alegre, Brazil. Demographic data, clinical, laboratory, endoscopic and radiological variables were collected in four moments: at diagnosis, at IFX indication, at week 14 of treatment and one year after the initiation of the treatment. Results: 121 patients were studied. Of these, 58 (47,93%) underwent IFX dose optimization. When analyzing epidemiological, clinical, laboratory and endoscopic factors related to a worse disease prognosis, there was a statistically significant difference between the groups (optimized and non-optimized) in relation to anemia (p = 0.019) and maintenance of elevated Creactive protein (CRP) at week 14 (p = 0.039). After adjusting for the multivariate model, only the maintenance of the increase in CRP in the week 14 remained statistically significant, with a 119% greater risk of optimizing treatment when compared to those with normal CRP. Conclusion: Among the factors analyzed, only maintaining CRP elevation at week 14 was associated with the need for IFX dose optimization. This is consistent with the literature that describes week 14 as an ideal time to assess serum levels of immunobiological as a predictor of sustained response. Thus, in a public health system and in the absence of serum dosage, this serum inflammatory marker could easily and cheaply guide the therapeutic decision.
- Published
- 2020
43. Mycobacterium avium subsp. paratuberculosis: características e infeção
- Author
-
Rodrigues, Renato Leitão and Assunção, Amélia
- Subjects
Ciências Médicas::Medicina Básica [Domínio/Área Científica] ,MAC ,Doença de Crohn ,Johne's Disease ,Mycobacteria ,Crohn's Disease ,Non-Tuberculous Mycobacteria ,Doenças Inflamatórias Intestinais ,Inflammatory Bowel Diseases ,Micobactéria ,Colite Ulcerosa ,Mycobacterium Avium Complex ,Mycobacterium avium subsp. paratuberculosis ,Doença de Johne ,Micobactérias Não Tuberculosas ,MAP ,Complexo Mycobacterium Avium ,Ulcerative Colitis ,NTM - Abstract
Submitted by Ana Moreira (anadsmoreira@ufp.pt) on 2020-06-29T12:08:58Z No. of bitstreams: 1 PPG_30113.pdf: 1530446 bytes, checksum: b32260ca4e844375557ac416ee5cc6c5 (MD5) Approved for entry into archive by azevedo@ufp.pt (azevedo@ufp.pt) on 2020-07-02T15:33:02Z (GMT) No. of bitstreams: 1 PPG_30113.pdf: 1530446 bytes, checksum: b32260ca4e844375557ac416ee5cc6c5 (MD5) Made available in DSpace on 2020-07-02T15:33:02Z (GMT). No. of bitstreams: 1 PPG_30113.pdf: 1530446 bytes, checksum: b32260ca4e844375557ac416ee5cc6c5 (MD5) Previous issue date: 2019-11-26
- Published
- 2019
44. Avaliação do perfil de citocinas inflamatórias e do nível de atividade física em pacientes com doença de Crohn antes e após terapia com infliximabe
- Author
-
Zanini, Karine Andrade Oliveira, Chebli, Júlio Maria Fonseca, Malaguti, Carla, Ribeiro, Tarsila Campanha da Rocha, Corrêa, José Otávio do Amaral, Sirimarco, Mauro Toledo, Barbosa, Katia Valeria Bastos Dias, and Bertges, Klaus Ruback
- Subjects
Immunopathogenesis ,Doença de Crohn ,Interleucina ,Physical activity ,Atividade física ,Doenças inflamatórias intestinais ,Interleukin ,Infliximab ,Inflammatory bowel disease ,Anti-TNF ,Infliximabe ,Crohn's disease ,CIENCIAS DA SAUDE [CNPQ] ,Imunopatogênese - Abstract
Pacientes com doença de Crohn (DC) apresentam menor nível de atividade física (AF). A terapia com infliximabe (IFX) pode induzir remissão clínica e favorecer o aumento da AF. Nós visamos avaliar a relação entre níveis de citocinas inflamatórias e AF em pacientes com DC moderada a grave, antes e após terapia com IFX. Quarenta e quatro pacientes com DC foram tratados com IFX durante 24 semanas. Dados clínicos, antropométricos, capacidade de exercício, força muscular, nível de AF (número de passos/dia [NP/dia] e tempo ativo [TA]) e níveis séricos do fator de necrose tumoral alfa (TNF-α), interferon gama (IFN-ɣ), interleucina (IL)-6 e IL-17 foram avaliados nas semanas zero e 24. Dados clínicos, antropométricos, capacidade de exercício e força muscular foram similares em pacientes com e sem melhora do nível de AF. Os pacientes em remissão clínica na 24ª semana (38/44; 86,4%), apresentaram diminuição significativa das citocinas, tanto nos pacientes que melhoraram AF quanto naqueles onde não houve incremento da AF. Por outro lado, no grupo sem remissão clínica houve aumento significativo da IL-6 e IL-17 nos pacientes com aumento do NP/dia e elevação da IL-6, IL-17 e TNF-α nos pacientes que aumentaram o TA. Os pacientes sem remissão e que não apresentaram melhora no NP/dia tiveram aumento do TNF-α. Conclui-se que, em pacientes com DC em remissão clínica induzida pelo IFX houve redução do nível sérico da IL-6, IL-17, TNF-α e IFN-ɣ, tanto nos que melhoraram, quanto naqueles que não obtiveram aumento da AF. Os pacientes que não responderam ao IFX, mas aumentaram a AF, tiveram aumento na IL-6 e IL-17. Patients with Crohn's disease (CD) have a lower level of physical activity (PA), and this behavior is determined in part by disease activity. Infliximab (IFX) therapy may induce clinical remission and, therefore, promote increased PA activity. However, the predictive factors of improvement of PA after clinical remission in CD are elusive. Therefore, we aimed to evaluate the profile of inflammatory cytokines and the possible increase of PA in patients with CD treated with IFX. In the cohort of 44 patients with CD who started treatment with IFX, 38 (86.4%) achieved clinical remission at the 24th week of treatment. Demographics, clinical, anthropometric, exercise capacity, muscle strength, PA level and serum levels of TNF-α (tumor necrosis factor alpha), IL-6 (interleukin), IL-17 and IFN-ɣ (interferon gamma) were evaluated at baseline and at week 24 in patients with and without improvement in PA level. Demographic, clinical and anthropometric data were similar in patients with and without improvement in the level of PA. All patients responding to IFX at the 24th week (n = 38 / 86.4%) presented a significant decrease in the cytokines evaluated. In the group without remission to IFX, a significant increase of IL-6 and IL-17 was observed in patients with increasing number of steps/day (NS/day), and elevation of IL-6, IL-17 and TNF-α in patients who increased your active time, measured by the accelerometer. Patients who did not respond to IFX, who did not show improvement in the NS/day, had only TNF-α increase. In conclusion, in patients with active CD in IFX-induced remission, the serum levels of IL-6, IL-17, TNF-α and IFN-ɣ were reduced and improvement in PA.
- Published
- 2019
45. Syndrome in Question
- Author
-
Guida Santos and Lourdes Sousa
- Subjects
Alopecia ,Alopecia areata ,Autoimmune diseases ,Crohn's disease ,Lichen planus ,oral ,Psoriasis ,Vitiligo ,Dermatology ,RL1-803 - Abstract
Multiple autoimmune syndrome is a rare condition, described by Humbert and Dupond in 1988. It is defined by the association of at least 3 autoimmune diseases in the same patient. Vitiligo is the most common skin condition in this syndrome. This article presents the case of a 31-year-old male with vitiligo, alopecia areata, Crohn's disease, psoriasis vulgaris and oral lichen planus. The rarity of this case is highlighted by the coexistence of four autoimmune skin diseases in association with Crohn's disease, never described in the literature.
- Published
- 2014
- Full Text
- View/download PDF
46. THE LIFE ON CLINICAL TREATMENT OF CROHN'S DISEASE.
- Author
-
Vieira, Fl via de Siqueira, Sonobe, Helena Megumi, de Oliveira, Marissa Silva, Lenza, Nariman de Felício Bortucan, Buetto, Luciana Scatralhe, and de Lima, Mariza Silva
- Abstract
Copyright of Journal of Nursing UFPE / Revista de Enfermagem UFPE is the property of Revista de Enfermagem UFPE and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2012
- Full Text
- View/download PDF
47. Colite histiocítica ulcerativa em um cão Boxer no Brasil.
- Author
-
Pavarini, Saulo Petinatti, Gomes, Danilo Carloto, Bandinelli, Marcele Bettim, de;o de Oliveira, Eduardo Conceiç&atil, Bandarra, Paulo Mota, Farias da Cruz, Claudio Estevão, and Driemeier, David
- Subjects
- *
ULCERATIVE colitis , *DOG diseases , *WHIPPLE'S disease , *CROHN'S disease - Abstract
Background: Histiocytic ulcerative colitis (HUC), also known as granulomatous Boxer's colitis or colitis similar to Whipple's disease is a condition affecting especially Boxer dogs. The disease is characterized by chronic increase in the defecation frequency, tenesmus, fetid dark-brown stools with blood streaks and mucus. Histopathology of a colorectal biopsy confirms the clinical diagnosis, when infiltrates of markedly PAS-positive macrophages are observed in the colonic lamina propria and submucosa. This communication reports a case of histiocytic ulcerative colitis in a Boxer dog in Brazil. Case: A Boxer dog, with one year and three months of age had been presenting, since it was nine months old, increased frequency of defecation, tenesmus, intermittent diarrhea, loose stools with streaks of liquid blood, and coprophagy; however, no weight loss or appetite loss were noticed. After an initial period of three months experiencing the aforementioned signs, the dog started with persistent diarrhea with bright red blood, mild prostration, weight loss, and voracious appetite. Because of continuous deteriorating condition and treatment refractoriness, the dog was euthanized. At necropsy, the colon was decreased in size with thickened mucosa and foci of ulceration, apart of enlarged mesenteric lymph nodes. Tissue fragments were collected and fixed in 10% formalin, processed following standard procedures for histopathology, and stained with Hematoxylin-Eosin (HE). Selected sections from samples of intestines and mesenteric lymph nodes were also stained with Periodic Acid Shiff (PAS) and Brown-Hopps adapted Gram Staining. Microscopic findings in the colon included infiltration with rounded to oval bulky macrophages, with eccentric nuclei and abundant eosinophilic and slightly granular cytoplasm. These macrophages were distributed in the basal lamina propria and submucosa, and there also was diffuse infiltration of lymphocytes and plasma cells. Extensive multifocal mucosal ulcerations with exposure of the submucosa were also observed. The cytoplasm of macrophages was strongly marked when stained by Periodic Acid Schiff. Macrófagos do cólon e do linfonodo mesentérico não coraram pela técnica de Gram. Discussion: This diagnosis of histiocytic ulcerative colitis was based on the clinical and pathological findings, especially the association of the clinical signs with the infiltrates of markedly PAS-positive macrophages within the colonic lamina propria and submucosa, which is considered a typical characteristic of the condition. The disease afflicts mainly young Boxer dogs, as it was recorded here. In most cases, there is neither weight loss, nor appetite loss, and the hair coat maintains a healthy appearance. However, in chronic cases such this described here, the dogs may show wasting. Ultrastructural and immunohistochemical findings in macrophages of HUC have indicated the participation of Escherichia coli in the etiopathogeny of the disease. The Boxer dog's predisposition to HUC has been attributed to a hereditary abnormality that confers invasion and persistence of an adherent E. coli group. This paper reports the importance of the histiocytic ulcerative colitis as an enteric condition affecting Boxer dogs also in Brazil. [ABSTRACT FROM AUTHOR]
- Published
- 2011
48. Enterografia por tomografia computadorizada: experiência inicial na avaliação das doenças do intestino delgado.
- Author
-
Luciana Costa-Silva, Martins, Tatiana, and do Carmo Friche Passos, Maria
- Subjects
- *
TOMOGRAPHY , *INTESTINAL diseases , *CROHN'S disease , *DIARRHEA , *POLYETHYLENE glycol - Abstract
OBJECTIVE: The present study was aimed at demonstrating the value of computed tomography enterography (CT enterography) and how this imaging method can be useful in the diagnostic elucidation and assessment of patients with small bowel diseases. MATERIALS AND METHODS: Retrospective evaluation of 35 patients submitted to CT enterography in a 16-row multidetector CT equipment from May/2008 to March/2009. All the patients received intravenous and neutral oral iodinated contrast agents (polyethylene glycol). Main indications were: Crohn's disease, diarrhea of undetermined origin and suspicion of neoplasia. RESULTS: A good correlation was observed between CT enterography findings and clinical, laboratory and endoscopic data related to the disease activity in patients with Crohn's disease. In 15 cases alterations compatible with Crohn's disease were identified, nine of them suggesting disease activity. A diagnosis was achieved in the majority of the patients with diarrhea. Carcinoid tumors were identified in two patients. CONCLUSION: CT enterography is a simple and effective method in the evaluation of inflammatory/neoplastic small bowel diseases, particularly in cases of Crohn's disease, indicating disease activity. One of the main advantages of this method is the possibility of evaluating associated mesenteric and extraintestinal alterations. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
49. Aspectos epidemiológicos das doenças intestinais inflamatórias na macrorregião de saúde leste do Estado de Minas Gerais.
- Author
-
Oliveira, Flávia Márcia, do Carmo Emerick, Ana Paula, and Soares, Elisângela Guimarães
- Subjects
INFLAMMATORY bowel diseases ,CROHN'S disease ,ULCERATIVE colitis ,PUBLIC health ,EPIDEMIOLOGY - Abstract
Copyright of Revista Ciência & Saúde Coletiva is the property of Associacao Brasileira de Pos-Graduacao em Saude Coletiva and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2010
- Full Text
- View/download PDF
50. Arterite de Takayasu e doença de Crohn: uma associação incomum.
- Author
-
Konopka, Clóvis, Braun, Stela Karine, and Machado, Gabriela
- Subjects
- *
ARTERITIS , *CROHN'S disease , *INFLAMMATORY bowel diseases , *STENOSIS , *VASCULITIS , *BLOOD pressure , *SUBCLAVIAN artery , *IMMUNOLOGIC diseases , *TOMOGRAPHY - Abstract
Takayasu's arteritis and Crohn's disease are chronic inflammatory diseases with unknown etiology. They rarely occur together in the same individual, with less than 30 cases reported in the literature. This case report describes this association in a 36-year-old woman with Crohn's disease and weak pulses in her left arm with blood pressure of 60/40 mmHg. Angiotomography showed segmental stenosis in the left subclavian artery and circumferential thickening of the aortic wall between T10 and L1, establishing the diagnosis of Takayasu's arteritis. Both are organspecific and immune-mediated diseases and exhibit granulomas and granulomatous vasculitis, which contribute to reinforce the hypothesis of a common immunologic origin. We believe that this is the first case of concomitant presence of these two diseases reported in the Brazilian literature. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.